Form 8-K

8-K — ACCENDRA HEALTH INC/VA/

Accession: 0001104659-26-093381

Filed: 2026-08-10

Period: 2026-08-09

CIK: 0000075252

SIC: 5047 (WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES)

Item: Entry into a Material Definitive Agreement

Item: Material Modifications to Rights of Security Holders

Item: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — tm2622667d3_8k.htm (Primary)

EX-3.1 — EXHIBIT 3.1 (tm2622667d3_ex3-1.htm)

EX-4.1 — EXHIBIT 4.1 (tm2622667d3_ex4-1.htm)

EX-99.1 — EXHIBIT 99.1 (tm2622667d3_ex99-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm2622667d3_8k.htm · Sequence: 1

false

--12-31

0000075252

2026-08-09

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):

August 9, 2026

Accendra

Health, Inc.

(Exact name of registrant as specified in its charter)

Virginia

001-09810

54-1701843

(State

or other jurisdiction of

incorporation or organization)

(Commission

File Number)

(I.R.S.

Employer

Identification Number)

4435 Waterfront Drive, Suite 300

Glen Allen, Virginia 23060

(Address, including zip code, of principal executive offices)

(804) 277-4304

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended

to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):

¨ Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of

the Act:

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on Which Registered

Common Stock, $2.00 par value per share

ACH

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth

company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities

Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ¨

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 1.01. Entry into a Material Definitive Agreement.

The

board of directors (the “Board of Directors”) of Accendra Health, Inc. (the “Company”) has taken actions to facilitate

the Company’s ability to preserve its net operating losses (“NOLs”) and certain other tax attributes. In connection

therewith, on August 9, 2026, the Board of Directors declared a dividend of one preferred share purchase right (a “Right”)

for each share of Common Stock, par value $2.00 per share, of the Company (the “Common Shares”) outstanding on August

20, 2026 (the “Record Date”) to the shareholders of record on that date. In connection with the distribution of the Rights,

the Company entered into a Section 382 Rights Agreement (the “Tax Asset Preservation Plan”), dated as of August 10, 2026,

between the Company and Computershare Trust Company, N.A., as rights agent. Each Right entitles the registered holder to purchase from

the Company one one-thousandth of a share of Series C Cumulative Preferred Stock, par value $100 per share, of the Company (the “Preferred

Shares”) at a price of $15.00 per one one-thousandth of a Preferred Share represented by a Right (the “Purchase Price”),

subject to adjustment. All capitalized terms used but not defined herein shall have the meaning

given to them in the Tax Asset Preservation Plan.

The purpose of the Tax Asset

Preservation Plan is to facilitate the Company’s ability to preserve its NOLs and its other tax attributes in order to be able to

offset potential future taxable income for U.S. federal income tax purposes. The Company’s ability to use its NOLs and other tax

attributes would be substantially limited if it experiences an “ownership change,” as such term is defined in Section 382

of the Internal Revenue Code of 1986, as amended (the “Code”). A company generally experiences an ownership change if the

percentage of the value of its stock owned by certain “5-percent shareholders,” as such term is defined in Section 382

of the Code, increases by more than 50 percentage points over a rolling three-year period. The Tax Asset Preservation Plan is intended

to, among other things, reduce the likelihood of an ownership change under Section 382 of the Code by deterring any Person or group of

affiliated or associated Persons from acquiring Beneficial Ownership (as defined below) of 4.9% or more of the outstanding Common Shares.

The Rights are in all respects

subject to and governed by the provisions of the Tax Asset Preservation Plan. The following description of the Tax Asset Preservation

Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the Tax Asset Preservation Plan,

which is attached hereto as Exhibit 4.1 and incorporated herein by reference.

Distribution Date; Exercisability; Expiration

Initially, the Rights will

be attached to all Common Share certificates (or other evidence of book-entry or other uncertificated ownership) and no separate certificates

evidencing the Rights (“Right Certificates”) will be issued. Until the Distribution Date (as defined below), the Rights will

be transferred with and only with the Common Shares. As long as the Rights are attached to the Common Shares, the Company will issue one

Right with each new Common Share so that all such Common Shares will have Rights attached (subject to certain limited exceptions).

The Rights will separate and begin trading separately from the Common

Shares, and Right Certificates will be caused to evidence the Rights, on the earlier to occur of (i) the Close of Business on the

tenth day following the acquisition of Beneficial Ownership of 4.9% or more of the outstanding Common Shares by a Person or group of affiliated

or associated Persons (an “Acquiring Person”) (or, in the event that the Board of Directors determines to effect an exchange

in accordance with the terms of the Tax Asset Preservation Plan and the Board of Directors determines that a later date is advisable,

then such later date) and (ii) the Close of Business on the tenth Business Day (or such later date as may be determined by action

of the Board of Directors prior to such time as any Person becomes an Acquiring Person) following the commencement of a tender offer or

exchange offer the consummation of which would result in the Beneficial Ownership by a Person or group of 4.9% or more of the outstanding

Common Shares (the earlier of such dates, the “Distribution Date”). As soon as practicable after the Distribution Date, unless

the Rights are recorded in book-entry or other uncertificated form, the Company will prepare and cause the Right Certificates to be sent

to each record holder of Common Shares as of the Distribution Date.

An “Acquiring Person”

is defined in the Tax Asset Preservation Plan to include any Person (other than an Exempt Person) who or which, together with all affiliates

and associates of such Person, is the Beneficial Owner of 4.9% or more of the Common Shares then outstanding, but will not include (i) the

Company, (ii) any subsidiary of the Company, (iii) any employee benefit plan of the Company or of any subsidiary of the Company,

(iv) any entity holding Common Shares for or pursuant to the terms of any such employee benefit plan or (v) any Person who or

which, together with all affiliates and associates of such Person, at the time of the first public announcement of the Tax Asset Preservation

Plan, is a Beneficial Owner of 4.9% or more of the Common Shares then outstanding (a “Grandfathered Shareholder”);

however, if a Grandfathered Shareholder becomes, after such time, the Beneficial Owner (other than pursuant to the vesting or exercise

of any equity awards issued to a member of the Board of Directors or pursuant to additional grants of any such equity awards to a member

of the Board of Directors) of any additional Common Shares (regardless of whether, thereafter or as a result thereof, there is an increase,

decrease or no change in the percentage of Common Shares then outstanding Beneficially Owned by such Grandfathered Shareholder) then such

Grandfathered Shareholder will be deemed to be an Acquiring Person unless, upon such acquisition of Beneficial Ownership of additional

Common Shares, such Person is not the Beneficial Owner of 4.9% or more of the Common Shares then outstanding. Additionally, that upon

the first decrease of a Grandfathered Shareholder’s Beneficial Ownership below 4.9%, such Grandfathered Shareholder will no longer

be deemed to be a Grandfathered Shareholder. If after the time of the first public announcement of the Tax Asset Preservation Plan, any

agreement, arrangement or understanding pursuant to which any Grandfathered Shareholder is deemed to be the Beneficial Owner of Common

Shares is, directly or indirectly, replaced, extended amended or substituted with respect to the same or different Common Shares for any

reason (including, without limitation, because it expired, was settled in whole or in part, terminated or no longer confers any benefit

to or imposes any obligation on the Grandfathered Shareholder (or, as applicable, an affiliate or associate of the Grandfathered Shareholder)),

then such agreement, arrangement or understanding will be considered the acquisition of Beneficial Ownership of additional Common Shares

by the Grandfathered Shareholder and render such Grandfathered Shareholder an Acquiring Person for purposes of the Tax Asset Preservation

Plan unless, upon such acquisition of Beneficial Ownership of additional Common Shares, such Person is not the Beneficial Owner of 4.9%

or more of the Common Shares then outstanding.

“Beneficial Ownership”

is defined in the Tax Asset Preservation Plan to include any securities (i) that a Person actually owns (directly or indirectly) or would

be deemed to directly, indirectly or constructively own (as determined for purposes of Section 382 of the Code and the Treasury Regulations

promulgated thereunder), including any coordinated acquisition of securities by any Persons who have a formal or informal understanding

with respect to such acquisition (to the extent that ownership of such securities would be attributed to such Persons under Section 382

of the Code and the Treasury Regulations promulgated thereunder), (ii) that such Person beneficially owns, directly or indirectly, as

determined pursuant to Rule 13d-3 of the Exchange Act as in effect on the date of the Tax Asset Preservation Plan, including pursuant

to any contract, arrangement, understanding, relationship, or otherwise as set forth in Rule 13d-3, but only if the effect of such arrangement,

understanding, relationship, or otherwise is to treat such Persons as an “entity” under Section 1.382-3(a)(1) of the Treasury

Regulations; or (iii) that are Beneficially Owned (within the meaning of the preceding subsections of this definition), directly or indirectly,

by any other Person with which such Person has any agreement, arrangement or understanding (whether or not in writing and other than customary

agreements with and between underwriters and selling group members with respect to a bona fide public offering of securities), but only

if the effect of such agreement, arrangement or understanding is to treat such Persons as an “entity” under Section 1.382-3(a)(1)

of the Treasury Regulations; however, a Person will not be deemed the “Beneficial Owner” of, or to “Beneficially Own,”

any security if such agreement, arrangement or understanding (a) arises solely from a revocable proxy or consent given in response to

a public proxy or consent solicitation made pursuant to, and in accordance with, the applicable provisions of the Exchange Act and (b)

is not also then reportable by such Person on Schedule 13D under the Exchange Act (or any comparable or successor report). The phrase

“then outstanding,” when used with reference to a Person’s Beneficial Ownership of securities of the Company, means

the number of such securities then issued and outstanding together with the number of such securities not then actually issued and outstanding

which such Person would be deemed to Beneficially Own pursuant to the Tax Asset Preservation Plan.

The

Rights are not exercisable until the Distribution Date. The Rights will expire on the earliest to occur of (i) the date on which

the Board of Directors determines in its sole discretion that (A) the Tax Asset Preservation Plan is no longer necessary for the preservation

of material NOLs or tax attributes or (B) the NOLs and tax attributes have been fully utilized and may no longer be carried forward and

(ii) the Close of Business on August 10, 2029 (the “Final Expiration Date”).

Exempt Persons and Transactions

The Board of Directors may, in its sole and absolute

discretion, determine that a Person is exempt from the Tax Asset Preservation Plan (an “Exempt Person”), so long as such determination

is made prior to such time as such Person becomes an Acquiring Person. Any Person will cease to be an Exempt Person if the Board of Directors

makes a contrary determination with respect to such Person regardless of the reason therefor. In addition, the Board of Directors may,

in its sole and absolute discretion, exempt any transaction from triggering the Tax Asset Preservation Plan, so long as the determination

in respect of such exemption is made prior to such time as any Person becomes an Acquiring Person. Any Person, together with all affiliates

and associates of such Person, who proposes to acquire 4.9% or more of the outstanding Common Shares may apply to the Board of Directors

in advance for an exemption in accordance with and pursuant to the terms of the Tax Asset Preservation Plan.

Flip-in Event

If a Person or group becomes an Acquiring Person

at any time after the date of the Tax Asset Preservation Plan (with certain limited exceptions), the Rights will become exercisable for

Common Shares having a value equal to two times the exercise price of the Right. From and after the announcement that any Person has become

an Acquiring Person, if the Rights evidenced by a Right Certificate are or were acquired or Beneficially Owned by an Acquiring Person

or any associate or affiliate of an Acquiring Person, such Rights will become void, and any holder of such Rights will thereafter have

no right to exercise such Rights. If the Board of Directors so elects, the Company may deliver upon payment of the exercise price of a

Right an amount of cash, securities or other property equivalent in value to the Common Shares issuable upon exercise of a Right.

Exchange

At any time after any Person becomes an Acquiring

Person, the Board of Directors may exchange the Rights (other than Rights owned by any Person which have become void), in whole or in

part, at an exchange ratio of one Common Share per Right (subject to adjustment). The Company may issue, transfer or deposit such Common

Shares (or other property as permitted under the Tax Asset Preservation Plan) to or into a trust or other entity created upon such terms

as the Board of Directors may determine and may direct that all holders of Rights receive such Common Shares or other property only from

the trust or other entity. In the event that the Board of Directors determines, before the Distribution Date, to effect an exchange, the

Board of Directors may delay the occurrence of the Distribution Date to such time as it deems advisable.

Redemption

At any time prior to the earlier to occur of (i)

the Close of Business on the tenth day following the Stock Acquisition Date (as defined in the Tax Asset Preservation Plan) (or, if the

tenth day following the Stock Acquisition Date occurs before the Record Date, the Close of Business on the Record Date) and (ii) the Final

Expiration Date, the Board of Directors may redeem the Rights in whole, but not in part, at a price of $0.001 per Right (the “Redemption

Price”). The redemption of the Rights may be made effective at such time, on such basis and with such conditions as the Board of

Directors in its sole discretion may establish. Immediately upon any redemption of the Rights, the right to exercise the Rights will terminate

and the only right of the holders of Rights will be to receive the Redemption Price.

Amendment

The terms of the Rights may be amended by the

Board of Directors without the consent of the holders of the Rights, except that at any time after the Close of Business on the tenth

day following the Stock Acquisition Date (or, if the tenth day following the Stock Acquisition Date occurs before the Record Date, the

Close of Business on the Record Date), no such amendment may adversely affect the interests of the holders of the Rights (other than the

Acquiring Person and its affiliates and associates).

Preferred Stock Rights

Each one-thousandth of a Preferred Share will entitle the holder thereof

to the same dividends and liquidation rights as if the holder held one Common Share and will be treated the same as a Common Share in

the event of a merger, consolidation or other share exchange.

Rights of Holders

Until a Right is exercised, the holder thereof,

as such, will have no rights as a shareholder of the Company, including, without limitation, the right to vote or to receive dividends.

Item 3.03. Material Modifications to Rights of Security Holders.

The information set forth in Items 1.01 and 5.03

of this Current Report on Form 8-K is incorporated herein by reference.

Item 5.03. Amendments to Articles of Incorporation or Bylaws;

Change in Fiscal Year.

In connection with the adoption of the Tax Asset

Preservation Plan, the Board of Directors approved the Articles of Amendment designating the Series C Cumulative Preferred Stock, which

the Company filed with the Secretary of the Commonwealth of Virginia. A copy of the Articles of Amendment is attached hereto as Exhibit

3.1 and incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

On August 10, 2026, the Company

issued a press release, announcing the adoption of the Tax Asset Preservation Plan. The Company is furnishing the press release attached

hereto as Exhibit 99.1 pursuant to Item 7.01 of Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this

Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act

of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing

under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

The following materials are filed as exhibits

to this Current Report on Form 8-K.

Exhibit No.

Description

3.1

Articles of Amendment designating Series C Cumulative Preferred Stock of Accendra Health, Inc., as filed with the Secretary of the Commonwealth of Virginia on August 10, 2026.

4.1

Section 382 Rights Agreement, dated as of August 10, 2026, between Accendra Health, Inc. and Computershare Trust Company, N.A., as rights agent.

99.1

Accendra Health, Inc. Press Release, dated August 10, 2026 (furnished pursuant to Item 7.01).

104

Cover Page Interactive Data File (embedded within the inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 10, 2026

ACCENDRA HEALTH, INC.

By:

/s/

Jonathan A. Leon

Jonathan

A. Leon

Executive

Vice President and Chief Financial Officer

EX-3.1 — EXHIBIT 3.1

EX-3.1

Filename: tm2622667d3_ex3-1.htm · Sequence: 2

Exhibit 3.1

ARTICLES OF AMENDMENT

TO THE AMENDED AND RESTATED

ARTICLES OF INCORPORATION OF

ACCENDRA HEALTH, INC.

The undersigned, on behalf of the corporation

set forth below, pursuant to Title 13.1, Chapter 9, Article 11 of the Code of Virginia, states as follows:

Name. The name of the corporation

is ACCENDRA HEALTH, INC.

Text of Amendment. The Amended

and Restated Articles of Incorporation of the Corporation (the “Articles of Incorporation”) are amended to add the

following to Part A of Article III (the “Amendment”):

7.           Series

C Cumulative Preferred Stock.

The shares of this series

shall be designated as Series C Cumulative Preferred Stock (the “Series C Cumulative Preferred Stock”), and the number

of shares constituting the Series C Cumulative Preferred Stock shall be 100,000. Such number of shares may be increased or decreased by

resolution of the Board of Directors; provided, that no decrease shall reduce the number of shares of Series C Cumulative Preferred

Stock to a number less than the number of shares then outstanding plus the number of shares reserved for issuance upon the exercise of

outstanding options, rights or warrants or upon the conversion of any outstanding securities issued by the Corporation convertible into

Series C Junior Cumulative Preferred Stock. The Series C Junior Cumulative Preferred Stock shall have the following preferences, limitations

and relative rights:

Section 1.      Dividends and

Distributions.

(A)       Subject

to the rights of the holders of any shares of any series of preferred stock, par value $100.00 per share, of the Corporation (the “Cumulative

Preferred Stock”) (or any other stock of the Corporation) ranking prior and superior to the Series C Cumulative Preferred Stock

with respect to dividends, the holders of shares of Series C Cumulative Preferred Stock shall be entitled to receive, when, as and if

declared by the Board of Directors out of funds legally available for the purpose, quarterly dividends payable in cash on the last day

of March, June, September and December in each year (each such date a “Quarterly Dividend Payment Date”), commencing

on the first Quarterly Dividend Payment Date after the first issuance of a share or fraction of a share of Series C Cumulative Preferred

Stock, in an amount (if any) per share (rounded to the nearest cent), subject to the provision for adjustment hereinafter set forth, equal

to 1,000 times the aggregate per share amount of all cash dividends or other distributions, and 1,000 times the aggregate per share amount

(payable in kind) of all non-cash dividends or other distributions, other than a dividend payable in shares of common stock, par value

$2.00 per share of the Corporation (the “Common Stock”) or a subdivision of the outstanding shares of Common Stock

(by reclassification or otherwise) declared on the Common Stock since the immediately preceding Quarterly Dividend Payment Date or, with

respect to the first Quarterly Dividend Payment Date, since the first issuance of any share or fraction of a share of Series C Cumulative

Preferred Stock. In the event that the Corporation shall at any time declare or pay any dividend on the Common Stock payable in shares

of Common Stock, or effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification

or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then

in each such case the amount to which holders of shares of Series C Cumulative Preferred Stock were entitled immediately prior to such

event under the preceding sentence shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of

shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that

were outstanding immediately prior to such event.

(B)        The

Corporation shall declare a dividend or distribution on the Series C Cumulative Preferred Stock as provided in paragraph (A) of this

Section 1 immediately after it declares a dividend or distribution on the Common Stock (other than a dividend payable in shares of Common

Stock).

due pursuant to paragraph (A) of this Section 1 shall begin to accrue and be cumulative on outstanding shares of Series C Cumulative

Preferred Stock from the Quarterly Dividend Payment Date next preceding the date of issue of such shares, unless the date of issue of

such shares is prior to the record date for the first Quarterly Dividend Payment Date, in which case dividends on such shares shall begin

to accrue from the date of issue of such shares, or unless the date of issue is a Quarterly Dividend Payment Date or is a date after the

record date for the determination of holders of shares of Series C Cumulative Preferred Stock entitled to receive a quarterly dividend

and before such Quarterly Dividend Payment Date, in either of which events such dividends shall begin to accrue and be cumulative from

such Quarterly Dividend Payment Date. Accrued but unpaid dividends shall not bear interest. Dividends paid on the shares of Series C Cumulative

Preferred Stock in an amount less than the total amount of such dividends at the time accrued and payable on such shares shall be allocated

pro rata on a share-by-share basis among all such shares at the time outstanding. The Board of Directors may fix a record date for the

determination of holders of shares of Series C Cumulative Preferred Stock entitled to receive payment of a dividend or distribution declared

thereon, which record date shall be not more than 60 days prior to the date fixed for the payment thereof.

Section 2.      Voting

Rights. The holders of shares of Series C Junior Cumulative Preferred Stock shall have the following voting rights:

(A)       Subject

to the provision for adjustment hereinafter set forth, each share of Series C Cumulative Preferred Stock shall entitle the holder thereof

to 1,000 votes on all matters submitted to a vote of the shareholders of the Corporation. In the event that the Corporation shall

at any time declare or pay any dividend on the Common Stock payable in shares of Common Stock, or effect a subdivision or combination

or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares of

Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case the number of votes per share to which

holders of shares of Series C Cumulative Preferred Stock were entitled immediately prior to such event shall be adjusted by multiplying

such number by a fraction, the numerator of which is the number of shares of Common Stock outstanding immediately after such event and

the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.

(B)        Except

as otherwise provided in the Articles of Incorporation, including any other Articles of Amendment creating a series of Cumulative Preferred

Stock or any similar stock, or by law, the holders of shares of Series C Cumulative Preferred Stock and the holders of shares of Common

Stock and any other capital stock of the Corporation having general voting rights shall vote together as one class on all matters submitted

to a vote of shareholders of the Corporation.

as set forth herein, or as otherwise required by law, holders of Series C Cumulative Preferred Stock shall have no special voting rights

and their consent shall not be required (except to the extent they are entitled to vote with holders of Common Stock as set forth herein)

for taking any corporate action.

Section 3.      Certain Restrictions.

(A)       Whenever

quarterly dividends or other dividends or distributions payable on the Series C Cumulative Preferred Stock as provided in Section 1

are in arrears, thereafter and until all accrued and unpaid dividends and distributions, whether or not declared, on shares of Series

C Cumulative Preferred Stock outstanding shall have been paid in full, the Corporation shall not:

(i) declare or pay

dividends, or make any other distributions, on any shares of stock ranking junior (either as to dividends or upon liquidation, dissolution

or winding-up) to the Series C Cumulative Preferred Stock;

(ii) declare or pay

dividends, or make any other distributions, on any shares of stock ranking on a parity (either as to dividends or upon liquidation, dissolution

or winding-up) with the Series C Cumulative Preferred Stock, except dividends paid ratably on the Series C Cumulative Preferred Stock

and all such parity stock on which dividends are payable or in arrears in proportion to the total amounts to which the holders of all

such shares are then entitled; or

(iii) redeem or purchase

or otherwise acquire for consideration shares of any stock ranking junior (either as to dividends or upon liquidation, dissolution or

winding-up) to the Series C Cumulative Preferred Stock, provided that the Corporation may at any time redeem, purchase or otherwise acquire

shares of any such junior stock in exchange for shares of any stock of the Corporation ranking junior (as to dividends and upon dissolution,

liquidation or winding-up) to the Series C Cumulative Preferred Stock.

(B)        The

Corporation shall not permit any subsidiary of the Corporation to purchase or otherwise acquire for consideration any shares of stock

of the Corporation unless the Corporation could, under paragraph (A) of this Section 3, purchase or otherwise acquire such shares

at such time and in such manner.

Section 4.      Reacquired

Shares. Any shares of Series C Cumulative Preferred Stock purchased or otherwise acquired by the Corporation in any manner whatsoever

shall be retired and canceled promptly after the acquisition thereof. The Corporation shall take all such actions as are necessary to

cause all such shares to become authorized but unissued shares of Cumulative Preferred Stock that may be reissued as part of a new series

of Cumulative Preferred Stock subject to the conditions and restrictions on issuance set forth herein or in the Articles of Incorporation,

including any Articles of Amendment creating a series of Cumulative Preferred Stock or any similar stock, or as otherwise required by

law.

Section 5.      Liquidation, Dissolution

or Winding-Up.

(A)        Upon

any liquidation, dissolution or winding-up of the Corporation, voluntary or otherwise, no distribution shall be made to the holders of

stock ranking junior (either as to dividends or upon liquidation, dissolution or winding-up) to the Series C Cumulative Preferred Stock

unless, prior thereto, the holders of Series C Cumulative Preferred Stock shall have received an amount per share (the “Series

C Liquidation Preference”) equal to an amount per share, subject to the provision for adjustment hereinafter set forth, equal

to 1,000 times the aggregate amount to be distributed per share to holders of shares of Common Stock plus an amount equal to any

accrued and unpaid dividends. In the event that the Corporation shall at any time declare or pay any dividend on the Common Stock payable

in shares of Common Stock, or effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification

or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then

in each such case the aggregate amount to which holders of shares of Series C Cumulative Preferred Stock were entitled immediately prior

to such event under the preceding sentence shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number

of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock

that were outstanding immediately prior to such event.

(B)        If

there are not sufficient assets available to permit payment in full of the Series C Liquidation Preference and the liquidation preferences

of all other classes and series of stock of the Corporation, if any, that rank on a parity with the Series C Cumulative Preferred Stock

in respect thereof, then the assets available for such distribution shall be distributed ratably to the holders of the Series C Cumulative

Preferred Stock and the holders of such parity shares in proportion to their respective liquidation preferences.

the merger or consolidation of the Corporation into or with another entity nor the merger or consolidation of any other entity into or

with the Corporation shall be deemed to be a liquidation, dissolution or winding-up of the Corporation within the meaning of this Section

Section 6.      Consolidation,

Merger, Etc. If the Corporation shall enter into any consolidation, merger, combination or other transaction in which the shares of

Common Stock are exchanged for or changed into other stock or securities, cash and/or any other property, then in any such case each share

of Series C Cumulative Preferred Stock shall at the same time be similarly exchanged or changed into an amount per share, subject to the

provision for adjustment hereinafter set forth, equal to 1,000 times the aggregate amount of stock, securities, cash and/or any other

property (payable in kind), as the case may be, into which or for which each share of Common Stock is changed or exchanged. In the event

that the Corporation shall at any time declare or pay any dividend on the Common Stock payable in shares of Common Stock, or effect a

subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment

of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case the amount

set forth in the preceding sentence with respect to the exchange or change of shares of Series C Cumulative Preferred Stock shall be adjusted

by multiplying such amount by a fraction, the numerator of which is the number of shares of Common Stock outstanding immediately after

such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.

Section 7.      Amendment.

While any Series C Cumulative Preferred Stock is issued and outstanding, the Articles of Incorporation shall not be amended in any manner,

including in a merger or consolidation, which would alter, change or repeal the powers, preferences or special rights of the Series C

Cumulative Preferred Stock so as to affect them adversely without the affirmative vote of the holders of at least two-thirds of the outstanding

shares of Series C Cumulative Preferred Stock, voting together as a single class.

Section 8.      Rank.

The Series C Cumulative Preferred Stock shall rank, with respect to the payment of dividends and upon liquidation, dissolution and winding-up,

junior to all other series of Cumulative Preferred Stock, unless the terms of any such series shall provide otherwise, and shall rank

senior to the Common Stock as to such matters.

Date

of Adoption. The Amendment was adopted by the Board of Directors of the Corporation on August 9, 2026.

Basis for Approval by Directors Alone.

The Amendment was duly adopted by the Board of Directors without shareholder approval. Shareholder approval was not required pursuant

to Section 13.1-639 of the Virginia Stock Corporation Act and Part A.1 of Article III of the Articles of Incorporation.

[Signature Page Follows]

IN WITNESS WHEREOF, these

Articles of Amendment are executed on behalf of the Corporation by its duly authorized officer this 10th day of August, 2026.

ACCENDRA HEALTH, INC.

By:

/s/ Jonathan A. Leon

Name:

Jonathan A. Leon

Title:

Executive Vice President and Chief Financial Officer

[Signature Page to Articles

of Amendment]

EX-4.1 — EXHIBIT 4.1

EX-4.1

Filename: tm2622667d3_ex4-1.htm · Sequence: 3

Exhibit 4.1

SECTION 382 RIGHTS AGREEMENT

Dated as of August 10, 2026

between

ACCENDRA

HEALTH, INC.

and

Computershare

TRUST COMPANY, N.A.,

as Rights Agent

TABLE OF CONTENTS

Page

Section

Definitions

Section

Appointment of Rights Agent

Section

Issue of Right Certificates

Section

Form of Right Certificates

Section

Countersignature and Registration

Section

Transfer, Split-up, Combination and Exchange of Right

Certificates; Mutilated, Destroyed, Lost or Stolen Right Certificates

Section

Exercise of Rights; Purchase Price; Expiration Date

of Rights

Section

Cancellation and Destruction of Right Certificates

Section

Status and Availability of Preferred Shares

Section

10.

Preferred Shares Record Date

Section

11.

Adjustment of Purchase Price, Number of Shares or Number

of Rights

Section

12.

Certificate of Adjustment

Section

13.

[Reserved]

Section

14.

Fractional Rights and Fractional Shares

Section

15.

Rights of Action

Section

16.

Agreement of Right Holders

Section

17.

Right Certificate Holder Not Deemed a Stockholder

Section

18.

Concerning the Rights Agent

Section

19.

Merger or Consolidation or Change of Name of Rights

Agent

Section

20.

Rights and Duties of Rights Agent

Section

21.

Change of Rights Agent

Section

22.

Issuance of New Right Certificates

Section

23.

Redemption

Section

24.

Exchange

Section

25.

Notice of Certain Events

Section

26.

Notices

Section

27.

Supplements and Amendments

Section

28.

Successors

Section

29.

Benefits of this Agreement

Section

30.

Severability

Section

31.

Governing Law

Section

32.

Counterparts

Section

33.

Descriptive Headings and Construction

Section

34.

Administration

Section

35.

Force Majeure

Section

36.

Process to Seek Exemption

SECTION

382 RIGHTS AGREEMENT

This Section 382 Rights Agreement

(this “Agreement”), dated as of August 10, 2026, is between Accendra Health, Inc., a Virginia corporation (the “Company”),

and Computershare Trust Company, N.A., a federally chartered trust company, as rights agent (the “Rights Agent”).

The Company and certain of

its Subsidiaries have generated certain Tax Attributes (as defined below) for United States federal income tax purposes and the Company

therefore desires to avoid an “ownership change” within the meaning of Section 382 of the Code, including for purposes of

Section 383 of the Code, and to preserve the Company’s ability to utilize such Tax Attributes.

The Board of Directors of

the Company (the “Board of Directors”) has authorized and declared a dividend of one preferred share purchase right

(a “Right”) for each share of common stock, par value $2.00 per share, of the Company outstanding on the Close of

Business on August 20, 2026 (the “Record Date”) and has authorized the issuance of one Right with respect to each

additional Common Share issued by the Company between the Record Date and the earliest of (i) the Distribution Date, (ii) the Redemption

Date, and (iii) the Final Expiration Date, and additional Common Shares that shall become outstanding after the Distribution Date

as provided in Section 22 of this Agreement, each Right initially representing the right to purchase one one-thousandth of a Preferred

Share, subject to adjustment, upon the terms and subject to the conditions hereof.

Accordingly, in consideration

of the premises and the mutual agreements herein set forth, the parties agree as follows:

Section 1.

Definitions. For purposes of this Agreement, the following terms have the meanings indicated:

1.1

“Acquiring Person” means any Person (other than an Exempt Person) who or which, together with all Affiliates

and Associates of such Person, shall be the Beneficial Owner of 4.9% or more of the Common Shares then outstanding, but shall not include

(i) the Company, (ii) any Subsidiary of the Company, (iii) any employee benefit plan of the Company or of any Subsidiary

of the Company, (iv) any entity holding Common Shares for or pursuant to the terms of any such employee benefit plan or (v) any

Person who or which, together with all Affiliates and Associates of such Person, at the time of the first public announcement of this

Agreement, is a Beneficial Owner of 4.9% or more of the Common Shares then outstanding (a “Grandfathered Shareholder”);

provided that if a Grandfathered Shareholder becomes, after such time, the Beneficial Owner (other than pursuant to the vesting

or exercise of any equity awards issued to a member of the Board of Directors or pursuant to additional grants of any such equity awards

to a member of the Board of Directors) of any additional Common Shares (regardless of whether, thereafter or as a result thereof, there

is an increase, decrease or no change in the percentage of Common Shares then outstanding Beneficially Owned by such Grandfathered Shareholder)

then such Grandfathered Shareholder shall be deemed to be an Acquiring Person unless, upon such acquisition of Beneficial Ownership of

additional Common Shares, such Person is not the Beneficial Owner of 4.9% or more of the Common Shares then outstanding; provided,

further, that upon the first decrease of a Grandfathered Shareholder’s Beneficial Ownership below 4.9%, such Grandfathered

Shareholder shall no longer be deemed to be a Grandfathered Shareholder and this clause (v) shall have no further force or effect with

respect to such Person. For the avoidance of doubt, if after the time of the first public announcement of this Agreement, any agreement,

arrangement or understanding pursuant to which any Grandfathered Shareholder is deemed to be the Beneficial Owner of Common Shares is,

directly or indirectly, replaced, extended, amended or substituted with respect to the same or different Common Shares for any reason

(including, without limitation, because it expired, was settled in whole or in part, terminated or no longer confers any benefit to or

imposes any obligation on the Grandfathered Shareholder (or, as applicable, an Affiliate or Associate of the Grandfathered Shareholder)),

then such agreement, arrangement or understanding shall be considered the acquisition of Beneficial Ownership of additional Common Shares

by the Grandfathered Shareholder and render such Grandfathered Shareholder an Acquiring Person for purposes of this Agreement unless,

upon such acquisition of Beneficial Ownership of additional Common Shares, such Person is not the Beneficial Owner of 4.9% or more of

the Common Shares then outstanding.

- 1 -

Notwithstanding the foregoing,

no Person shall become an Acquiring Person solely as the result of an acquisition or redemption of Common Shares by the Company which,

by reducing the number of shares outstanding, increases the proportionate number of shares Beneficially Owned by such Person to 4.9%

(or such other percentage as would otherwise result in such Person becoming an Acquiring Person) or more of the Common Shares then outstanding;

provided that if a Person would, but for the provisions of this paragraph, become an Acquiring Person by reason of an acquisition

or redemption of Common Shares by the Company and shall, after such acquisition or redemption by the Company, become the Beneficial Owner

of any additional Common Shares at any time such that the Person is or thereby becomes the Beneficial Owner of 4.9% (or such other percentage

as would otherwise result in such Person becoming an Acquiring Person) or more of the Common Shares then outstanding (other than Common

Shares acquired solely as a result of corporate action of the Company not caused, directly or indirectly, by such Person), then such

Person shall be deemed to be an Acquiring Person.

Notwithstanding the foregoing,

if the Board of Directors, with the concurrence of a majority of the members of the Board of Directors who are not, and are not representatives,

nominees, Affiliates or Associates of, such Person or an Acquiring Person, determines in good faith that a Person that would otherwise

be an Acquiring Person upon a certain acquisition of Beneficial Ownership of Common Shares has become so inadvertently (including because

(i) such Person was unaware that it Beneficially Owned a percentage of Common Shares that would otherwise cause such Person to be an

Acquiring Person or (ii) such Person was aware of the extent of its Beneficial Ownership of Common Shares but had no actual knowledge

of the consequences of such Beneficial Ownership under this Agreement), then such Person shall not be deemed to have become an Acquiring

Person with respect to such acquisition of Beneficial Ownership of Common Shares. Notwithstanding the foregoing, if a bona fide swaps

dealer who would otherwise be an Acquiring Person has become so as a result of its actions in the ordinary course of its business that

the Board of Directors determines, in its sole discretion, were taken without the intent or effect of evading or assisting any other

Person to evade the purposes and intent of this Agreement, then, and unless and until the Board of Directors shall otherwise determine,

such Person shall not be deemed to be an Acquiring Person.

- 2 -

Notwithstanding the foregoing,

no Person shall become an Acquiring Person solely as a result of an Exempt Transaction.

Notwithstanding the foregoing,

no regulated investment company under Section 851 of the Code shall be deemed to be an Acquiring Person, unless the Board of Directors

determines, in its reasonable discretion, that such regulated investment company is deemed to Beneficially Own more than 4.9% or more

of the Common Shares then outstanding under the applicable standards of Treasury Regulations Section 1.382-3(a). In determining whether

any regulated investment company is an Acquiring Person, the filing of a statement under Section 13 of the Exchange Act with respect

to such regulated investment company shall not be deemed to establish that such regulated investment company has acquired Beneficial

Ownership of 4.9% or more of the Common Shares then outstanding; provided that the Board of Directors shall be entitled to rely

upon any such filing unless such regulated investment company provides information and diligence that permits the Board of Directors

to conclude, in its reasonable discretion, that such regulated investment company has not acquired Beneficial Ownership of 4.9% or more

of the Common Shares then outstanding pursuant to the applicable standards of Treasury Regulations Section 1.382-3(a).

Notwithstanding the

definition of Acquiring Person under this Agreement, the Board of Directors may also determine that any Person is an Acquiring Person

under this Agreement if such Person becomes the Beneficial Owner of 4.9% (by value) or more of the Common Shares then outstanding (as

the term “stock” is defined in Treasury Regulations Sections 1.382-2(a)(3) and 1.382-2T(f)(18)).

1.2

“Affiliate” and “Associate” shall have the respective meanings ascribed to such terms

in Rule 12b-2 promulgated under the Exchange Act, as in effect on the date of this Agreement.

1.3

A Person shall be deemed the “Beneficial Owner” of and shall be deemed to “Beneficially Own,”

or have “Beneficial Ownership” of, any securities:

1.3.1        that

such Person actually owns (directly or indirectly) or would be deemed to directly, indirectly or constructively own (as determined for

purposes of Section 382 of the Code and the Treasury Regulations promulgated thereunder), including any coordinated acquisition of securities

by any Persons who have a formal or informal understanding with respect to such acquisition (to the extent that ownership of such securities

would be attributed to such Persons under Section 382 of the Code and the Treasury Regulations promulgated thereunder);

1.3.2

that such Person beneficially owns, directly or indirectly, as determined pursuant to Rule 13d-3 of the Exchange Act as in

effect on the date of this Agreement, including pursuant to any contract, arrangement, understanding, relationship, or otherwise as set

forth in Rule 13d-3, but only if the effect of such arrangement, understanding, relationship, or otherwise is to treat such Persons as

an “entity” under Section 1.382-3(a)(1) of the Treasury Regulations; or

- 3 -

1.3.3

that are Beneficially Owned (within the meaning of the preceding subsections of this Section 1.3), directly or indirectly,

by any other Person with which such Person has any agreement, arrangement or understanding (whether or not in writing and other than

customary agreements with and between underwriters and selling group members with respect to a bona fide public offering of securities),

but only if the effect of such agreement, arrangement or understanding is to treat such Persons as an “entity” under Section

1.382-3(a)(1) of the Treasury Regulations; provided, however, that a Person shall not be deemed the “Beneficial Owner” of,

or to “Beneficially Own,” any security if such agreement, arrangement or understanding (i) arises solely from a revocable

proxy or consent given in response to a public proxy or consent solicitation made pursuant to, and in accordance with, the applicable

provisions of the Exchange Act and (ii) is not also then reportable by such Person on Schedule 13D under the Exchange Act (or any comparable

or successor report).

Notwithstanding anything

in this definition of Beneficial Owner to the contrary, the phrase “then outstanding,” when used with reference to a Person’s

Beneficial Ownership of securities of the Company, means the number of such securities then issued and outstanding together with the

number of such securities not then actually issued and outstanding which such Person would be deemed to Beneficially Own hereunder.

1.4

“Business Day” means any day other than a Saturday, a Sunday or a day on which banking institutions in

the state of New York are authorized or obligated by law or executive order to close.

1.5

“Close of Business” on any given date means 5:00 p.m., New York time, on such date; provided

that if such date is not a Business Day, it means 5:00 p.m., New York time, on the next succeeding Business Day.

1.6

“Code” means the Internal Revenue Code of 1986, as amended.

1.7

“Common Shares” means the shares of common stock, par value $2.00 per share, of the Company. “Common

Shares,” when used with reference to any Person other than the Company, means the capital stock (or equity interest) with the

greatest voting power of such other Person or, if such other Person is a Subsidiary of another Person, the Person or Persons which ultimately

control such first-mentioned Person.

1.8

“Common Stock Equivalents” has the meaning set forth in Section 11.1.3(ii)(C).

1.9

“Current Per Share Market Price” has the meaning set forth in Section 11.4.1.

1.10

“Current Value” has the meaning set forth in Section 11.1.3(i)(A).

1.11

“Distribution Date” has the meaning set forth in Section 3.1.

1.12

“Equivalent Preferred Shares” has the meaning set forth in Section 11.2.

1.13

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

1.14

“Exchange Property” has the meaning set forth in Section 24.6.

1.15

“Exchange Ratio” has the meaning set forth in Section 24.1.

- 4 -

1.16

“Exchange Recipients” has the meaning set forth in Section 24.6.

1.17

“Exempt Person” means any Person that the Board of Directors determines is exempt from this Agreement,

which determination shall be made in the sole and absolute discretion of the Board of Directors; provided, that no Person shall

qualify as an Exempt Person unless such determination is made, prior to such time as such Person becomes an Acquiring Person; provided,

further, that any Person will cease to be an Exempt Person if the Board of Directors makes a contrary determination with respect

to such Person regardless of the reason therefor.

1.18

“Exempt Transaction” means any transaction that the Board of Directors determines is exempt from this Agreement,

which determination shall be made in the sole and absolute discretion of the Board of Directors (provided, that no transaction

shall qualify as an Exempt Transaction unless such determination is made prior to such time as any Person becomes an Acquiring Person).

1.19

“Exemption Request” has the meaning set forth in Section 36.

1.20

“Final Expiration Date” means the earliest to occur of (i) the date on which the Board of Directors determines

in its sole discretion that (A) this Agreement is no longer necessary for the preservation of material Tax Attributes or (B) the Tax

Attributes have been fully utilized and may no longer be carried forward and (ii) the Close of Business on August 10, 2029.

1.21

“Grandfathered Shareholder” has the meaning set forth in Section 1.1.

1.22

“NYSE” means the New York Stock Exchange.

1.23

“Person” means any individual, firm, corporation, partnership, limited partnership, limited liability partnership,

business trust, limited liability company, unincorporated association or other entity, and shall include any successor (by merger or

otherwise) of such entity.

1.24

“Preferred Shares” means shares of Series C Cumulative Preferred Stock, par value $100.00 per share, of

the Company having such rights and preferences as are set forth in the form of Articles of Amendment set forth as Exhibit A hereto,

as the same may be amended from time to time.

1.25

“Purchase Price” has the meaning set forth in Section 7.2.

1.26

“Redemption Date” has the meaning set forth in Section 23.2.

1.27

“Redemption Price” has the meaning set forth in Section 23.1.

1.28

“Requesting Person” has the meaning set forth in Section 36.

1.29

“Right Certificate” means a certificate evidencing a Right substantially in the form of Exhibit B

hereto.

- 5 -

1.30

“Signature Guarantee” shall mean any guaranty of signature by an “eligible guarantor institution”

that is a member or participant in the Securities Transfer Agents Medallion Program or other comparable “signature guarantee program”

or insurance program in addition to, or in substitution for, the foregoing.

1.31

“Spread” has the meaning set forth in Section 11.1.3(i).

1.32

“Stock Acquisition Date” means the earlier of the date of (i) the public announcement by the Company

or an Acquiring Person that an Acquiring Person has become such (which, for purposes of this definition, shall include a statement on

Schedule 13D or Schedule 13G filed pursuant to the Exchange Act) and (ii) the public disclosure of facts by the Company or an Acquiring

Person that reveals the existence of an Acquiring Person or indicating that an Acquiring Person has become an Acquiring Person.

1.33

“Subsidiary” of any Person means any Person of which a majority of the voting power of the voting equity

securities or equity interest is owned, directly or indirectly, by such Person.

1.34

“Summary of Rights” means the Summary of Rights to Purchase Preferred Shares substantially in the form

of Exhibit C hereto.

1.35

“Tax Attributes” means any net operating loss carryovers, capital loss carryovers, general business credit

carryovers, Section 163(j) deferred interest carryovers, alternative minimum tax credit carryovers, foreign tax credit carryovers, and

investment credit or other tax credit carryovers, as well as any loss or deduction (whether actual or prospective) attributable to a

“net unrealized built-in loss” within the meaning of Section 382 of the Code and the Treasury Regulations promulgated thereunder,

of the Company or any of its Subsidiaries.

1.36

“Trading Day” means a day on which the principal national securities exchange on which a security is listed

or admitted to trading is open for the transaction of business or, if a security is not listed or admitted to trading on any national

securities exchange, a Business Day.

1.37

“Treasury Regulations” mean the final, temporary and proposed regulations of the Department of Treasury

under the Code and any successor regulations, including any amendments thereto.

1.38

“Trust” has the meaning set forth in Section 24.6.

Section 2.

Appointment of Rights Agent. The Company hereby appoints the Rights Agent to act as rights agent for the Company in accordance

with the express terms and conditions hereof (and no implied terms or conditions), and the Rights Agent hereby accepts such appointment.

The Company may from time to time appoint such co-rights agents as it may deem necessary or desirable (the term “Rights Agent”

being used herein to refer, collectively, to the initial Rights Agent together with any such co-rights agents), upon ten days’

prior written notice to the Rights Agent. The Rights Agent shall have no duty to supervise, and shall in no event be liable for, the

acts or omissions of any such co-rights agent. In the event that the Company appoints one or more co-rights agents, the respective duties

of the Rights Agent and any co-rights agent shall be as the Company shall reasonably determine, provided that such duties and

determination are consistent with the terms and provisions of this Agreement and that contemporaneously with such appointment, if any,

the Company shall notify the Rights Agent in writing thereof.

- 6 -

Section 3.

Issue of Right Certificates.

3.1

Until the earlier of (i) the Close of Business on the tenth day after the Stock Acquisition Date (or, in the event that

the Board of Directors determines on or before such tenth day to effect an exchange in accordance with Section 24 and determines that

a later date is advisable, such later date) and (ii) the Close of Business on the tenth Business Day (or such later date as may

be determined by action of the Board of Directors prior to such time as any Person becomes an Acquiring Person) after the date of the

commencement by any Person (other than the Company, any Subsidiary of the Company, any employee benefit plan of the Company or of any

Subsidiary of the Company, any entity holding Common Shares for or pursuant to the terms of any such benefit plan or any Exempt Person)

of a tender or exchange offer the consummation of which would result in any Person becoming an Acquiring Person (the earlier of (i) and

(ii) being herein referred to as the “Distribution Date”) (provided that if such tender or exchange offer is

terminated prior to the occurrence of a Distribution Date, then no Distribution Date shall occur as a result of such tender or exchange

offer), (A) the Rights will be evidenced by the certificates (or other evidence of book-entry or other uncertificated ownership)

for Common Shares registered in the names of the holders thereof (which shall also be deemed to be Right Certificates) and not by separate

Right Certificates (provided that each certificate (or other evidence of book-entry or other uncertificated ownership) representing

Common Shares outstanding as of the Close of Business on the Record Date evidencing the Rights shall be deemed to incorporate by reference

the terms of this Agreement, as amended from time to time), and (B) the right to receive Right Certificates will be transferable

only in connection with the transfer of Common Shares. As soon as practicable after the Distribution Date, the Company will prepare and

execute, the Rights Agent will countersign, and the Company will send or cause to be sent (and the Rights Agent will, if requested, at

the expense of the Company and upon receipt of all relevant information, send or cause to be sent) by first-class, postage-prepaid mail,

to each record holder of Common Shares as of the Distribution Date (other than any Acquiring Person or any Associate or Affiliate of

any Acquiring Person), at the address of such holder shown on the records of the Company, a Right Certificate, substantially in the form

of Exhibit B hereto, evidencing one Right for each Common Share so held, subject to adjustment as provided herein; provided

that the Rights may instead be recorded in book-entry or other uncertificated form, in which case such book-entries or other evidence

of ownership shall be deemed to be Right Certificates for all purposes of this Agreement; provided, further, that all procedures

relating to actions to be taken or information to be provided with respect to such Rights recorded in book-entry or other uncertificated

forms, and all requirements with respect to the form of any Right Certificate set forth in this Agreement, may be modified as necessary

or appropriate to reflect book-entry or other uncertificated ownership. As of the Distribution Date, the Rights will be evidenced solely

by such Right Certificates.

3.2

As soon as practicable after the Record Date, the Company will make available a copy of the Summary of Rights to any holder

of Rights who may request it prior to the Final Expiration Date. The Company shall provide the Rights Agent with written notice of the

occurrence of the Final Expiration Date and the Rights Agent shall not be deemed to have knowledge of the occurrence of the Final Expiration

Date, unless and until it shall have received such written notice.

- 7 -

3.3

Certificates for Common Shares which become outstanding (including reacquired Common Shares referred to in the last sentence

of this Section 3.3) after the Record Date but prior to the earliest of (i) the Distribution Date, (ii) the Redemption Date,

and (iii) the Final Expiration Date shall have impressed on, printed on, written on or otherwise affixed to them a legend in substantially

the following form:

This certificate also evidences and entitles

the holder hereof to certain Rights (as defined in the Rights Agreement (as defined below)) as set forth in the Section 382 Rights Agreement

between Accendra Health, Inc. and Computershare Trust Company, N.A., as Rights Agent (or any successor rights agent), dated as of August

10, 2026 (as it may from time to time be amended or supplemented pursuant to its terms, the “Rights Agreement”),

the terms of which are hereby incorporated herein by reference and a copy of which is on file at the principal executive offices of Accendra

Health, Inc. and the office or offices of Computershare Trust Company, N.A. designated for such purpose. The Rights are not exercisable

prior to the occurrence of certain events specified in the Rights Agreement. Under certain circumstances, as set forth in the Rights

Agreement, such Rights will be evidenced separately and will no longer be evidenced by this certificate. Accendra Health, Inc. will mail

to the holder of this certificate a copy of the Rights Agreement without charge after receipt of a written request therefor. Under certain

circumstances, Rights that are or were acquired or Beneficially Owned by an Acquiring Person (or an Affiliate or Associate of an Acquiring

Person (as such terms are defined in the Rights Agreement)), including such Rights held by a subsequent holder, may become null and void.

Notwithstanding this Section 3.3, the omission

of a legend shall not affect the enforceability of any part of this Agreement or the rights of any holder of the Rights. If the Company

purchases or acquires any Common Shares after the Record Date but prior to the Distribution Date, any Rights associated with such Common

Shares shall be deemed canceled and retired so that the Company shall not be entitled to exercise any Rights associated with the Common

Shares which are no longer outstanding. Rights shall be issued in respect of all Common Shares issued or disposed of (including upon

issuance or reissuance of Common Shares out of authorized but unissued shares) after the Record Date but prior to the earliest of the

Distribution Date, the Redemption Date, and the Final Expiration Date, or in certain circumstances provided in Section 22 hereof, after

the Distribution Date.

Section 4.

Form of Right Certificates. Right Certificates (and the forms of election to purchase Preferred Shares and of assignment to

be printed on the reverse thereof) shall be substantially the same as Exhibit B hereto and may have such marks of identification

or designation and such legends, summaries or endorsements printed thereon as the Company may deem appropriate and as are not inconsistent

with the provisions of this Agreement (but which do not affect the rights, duties, liabilities or responsibilities of the Rights Agent),

or as may be required to comply with any applicable law or with any rule or regulation made pursuant thereto or with any rule or regulation

of any stock exchange on which the Rights may from time to time be listed, or to conform to usage. Subject to the other provisions of

this Agreement, the Right Certificates shall entitle the holders thereof to purchase such number of one one-thousandths of a Preferred

Share as shall be set forth therein at the Purchase Price, but the amount and type of securities purchasable upon exercise and the Purchase

Price shall be subject to adjustment as provided herein.

- 8 -

Section 5.

Countersignature and Registration. Right Certificates shall be duly executed on behalf of the Company by any two of its Chairman

of the Board of Directors, its Chief Executive Officer, its President, any of its Vice Presidents, the Corporate Secretary, or the Assistant

Corporate Secretary, either manually or by facsimile signature or by other customary means of electronic transmission. Upon written request

by the Company, the Right Certificates shall be countersigned by the Rights Agent, either manually or by facsimile signature or by other

customary means of electronic transmission, by an authorized signatory of the Rights Agent, but it shall not be necessary for the same

signatory to countersign all of the Right Certificates hereunder. No Right Certificate shall be valid for any purpose unless so countersigned,

either manually or by facsimile or by other customary means of electronic transmission. If any officer of the Company who shall have

signed any of the Right Certificates shall cease to be such officer of the Company before countersignature by the Rights Agent and issuance

and delivery by the Company, such Right Certificates nevertheless may be countersigned by the Rights Agent and issued and delivered by

the Company with the same force and effect as though the Person that signed such Right Certificates had not ceased to be such officer

of the Company. Any Right Certificate may be signed on behalf of the Company by any Person that, at the actual date of the execution

of such Right Certificate, is a proper officer of the Company to sign such Right Certificate, even if at the date of the execution of

this Agreement such Person was not such an officer.

Following the Distribution

Date, and receipt by the Rights Agent of written notice to that effect and all other relevant information referred to in this Agreement,

the Rights Agent will keep or cause to be kept, at its office or offices designated for such purpose, books for registration of the transfer

of the Right Certificates issued hereunder. Such books shall show the names and addresses of the respective holders of the Right Certificates,

the number of Rights evidenced on its face by each of the Right Certificates, and the date of each of the Right Certificates.

Section 6.

Transfer, Split-up, Combination and Exchange of Right Certificates; Mutilated, Destroyed, Lost or Stolen Right Certificates.

6.1

Subject to the provisions of Section 14, at any time after the Distribution Date, and prior to the earlier of the Redemption

Date and the Final Expiration Date, any Right Certificate (other than a Right Certificate representing Rights that have become null and

void pursuant to Section 11.1.2 or that have been exchanged pursuant to Section 24) may be transferred, split up, combined or exchanged

for another Right Certificate, entitling the registered holder to purchase a like number of Preferred Shares as the Right Certificate

surrendered then entitled such holder to purchase. Any registered holder desiring to transfer, split up, combine or exchange any Right

Certificate shall make such request in writing delivered to the Rights Agent, and shall surrender (together with any required form of

assignment and certificate duly executed and properly completed) the Right Certificate to be transferred, split up, combined or exchanged

at the office or offices of the Rights Agent designated for such purpose, accompanied by a Signature Guarantee and such other documentation

as the Rights Agent may reasonably request. Neither the Rights Agent nor the Company shall be obligated to take any action whatsoever

with respect to the transfer, split-up, combination or exchange of any such surrendered Right Certificate until the registered holder

shall have properly completed and duly executed the certificate contained in the form of assignment on the reverse side of such Right

Certificate accompanied by a Signature Guarantee and shall have provided such additional evidence of the identity of the Beneficial Owner

(or former Beneficial Owner) of the Rights represented by such Right Certificate or the Affiliates or Associates thereof, or of any other

Person with which such Beneficial Owner or any of such Beneficial Owner’s Affiliates or Associates has any agreement, arrangement

or understanding (whether or not in writing) for the purpose of acquiring, holding, voting or disposing of any securities of the Company,

as the Company or the Rights Agent shall reasonably request, and such other documentation as the Rights Agent reasonably requests. Thereupon,

the Rights Agent shall countersign and deliver to the Person entitled thereto a Right Certificate or Right Certificates, as the case

may be, as so requested. The Company or the Rights Agent may require payment from the holders of the Right Certificates of a sum sufficient

for the payment of any tax or governmental charge that may be imposed in connection with any transfer, split-up, combination or exchange

of Right Certificates. If and to the extent the Company does require payment of any such taxes or governmental charges, the Company shall

give the Rights Agent prompt written notice thereof and the Rights Agent shall not deliver any Rights Certificate unless and until it

is satisfied that all such payments have been made, and the Rights Agent shall forward any such sum collected by it to the Company or

to such Persons as the Company specifies by written notice. The Rights Agent shall not have any duty or obligation to take any action

under any section of this Agreement that requires the payment of taxes and/or charges or governmental charges unless and until it is

satisfied that all such payments have been made.

- 9 -

6.2

Upon receipt by the Company and the Rights Agent of evidence reasonably satisfactory to them of the loss, theft, destruction

or mutilation of a Right Certificate (other than any Right Certificate representing Rights that have become null and void pursuant to

Section 11.1.2, that have been redeemed pursuant to Section 23 or that have been exchanged pursuant to Section 24), the identity

of the Beneficial Owner (or former Beneficial Owner) of the Rights represented by such Right Certificate or the Affiliates or Associates

thereof, or of any other Person with which such Beneficial Owner or any of such Beneficial Owner’s Affiliates or Associates has

any agreement, arrangement or understanding (whether or not in writing) for the purpose of acquiring, holding, voting or disposing of

any securities of the Company, as the Company or the Rights Agent shall request (including a Signature Guarantee and such other documentation

as the Rights Agent may reasonably request) and, in case of loss, theft or destruction, of indemnity or security satisfactory to them,

and, at the Company’s or the Rights Agent’s request, reimbursement to the Company and the Rights Agent of all reasonable

expenses incidental thereto, and, in case of mutilation, upon surrender to the Rights Agent and cancellation of the Right Certificate,

the Company will make and deliver a new Right Certificate of like tenor to the Rights Agent for countersignature and delivery to the

registered holder in lieu of the Right Certificate so lost, stolen, destroyed or mutilated.

Section 7.

Exercise of Rights; Purchase Price; Expiration Date of Rights.

7.1

The registered holder of any Right Certificate (other than a holder whose Rights have become void pursuant to Section 11.1.2,

have been redeemed pursuant to Section 23 or have been exchanged pursuant to Section 24) may exercise the Rights evidenced thereby in

whole or in part at any time after the Distribution Date upon surrender of the Right Certificate, with the appropriate form of election

to purchase on the reverse side thereof properly completed and duly executed, to the Rights Agent at the offices of the Rights Agent

designated for such purpose, accompanied by a Signature Guarantee and such other documentation as the Rights Agent may reasonably request,

together with payment of the Purchase Price multiplied by the number of one one-thousandths of a Preferred Share for which a Right that

is exercised is then exercisable and an amount equal to any applicable transfer tax or governmental charge required to be paid pursuant

to Section 9, prior to the earliest of (i) the Final Expiration Date, (ii) the time at which the Rights are redeemed pursuant

to Section 23, and (iii) the time at which the Rights are exchanged pursuant to Section 24.

- 10 -

7.2

The purchase price to be paid upon the exercise of each Right to purchase one one-thousandth of a Preferred Share represented

by a Right shall initially be $15.00 (the “Purchase Price”) and shall be payable in lawful money of the United States

of America in accordance with Section 7.3. Each Right shall initially entitle the holder to acquire one one-thousandth of a Preferred

Share upon exercise of the Right. The Purchase Price and the number of Preferred Shares or other securities for which a Right is exercisable

shall be subject to adjustment from time to time as provided in Section 11.

7.3

Upon receipt of a Right Certificate representing exercisable Rights, with the form of election to purchase and certificate

properly completed and duly executed, accompanied by payment of the Purchase Price for the number of Rights exercised and an amount equal

to any applicable transfer tax or governmental charge required to be paid by the holder of such Right Certificate in accordance with

Section 9 by cash, certified check, cashier’s check or money order payable to the order of the Company, the Rights Agent shall

thereupon promptly: (i)(A) requisition from any transfer agent of the Preferred Shares (or from the Company if there shall be no

such transfer agent, or make available, if the Rights Agent is the transfer agent) certificates for the number of Preferred Shares to

be purchased, and the Company hereby irrevocably authorizes its transfer agent to comply with all such requests, or (B) requisition

from any depositary agent for the Preferred Shares depositary receipts representing such number of Preferred Shares as are to be purchased

(in which case certificates for the Preferred Shares represented by such receipts shall be deposited by the transfer agent with the depositary

agent), and the Company hereby directs any such depositary agent to comply with such request; (ii) when necessary to comply with

this Agreement, requisition from the Company the amount of cash to be paid in lieu of issuance of fractional Preferred Shares in accordance

with Section 14 or Section 24; (iii) after receipt of such certificates or depositary receipts, cause the same to be delivered to

or upon the order of the registered holder of such Right Certificate, registered in such name or names as may be designated in writing

by such holder; and (iv) when necessary to comply with this Agreement, after receipt of cash in lieu of fractional Preferred Shares

pursuant to clause (ii), deliver such cash to or upon the order of the registered holder of such Right Certificate. In the event that

the Company is obligated to issue other securities of the Company, pay cash and/or distribute other property pursuant to this Agreement,

the Company will make all arrangements necessary so that such other securities, cash and/or other property are available for distribution

by the Rights Agent, if and when necessary to comply with this Agreement, and until so received, the Rights Agent shall have no duties

or obligations with respect to such securities, cash and/or other assets.

7.4

If the registered holder of any Right Certificate shall exercise less than all the Rights evidenced thereby, a new Right Certificate

evidencing Rights equivalent to the Rights remaining unexercised shall be issued by the Rights Agent and delivered to the registered

holder of such Right Certificate or to such holder’s duly authorized assigns, subject to the provisions of Section 14.

- 11 -

7.5

Notwithstanding anything in this Agreement or the Right Certificate to the contrary, neither the Rights Agent nor the Company

shall be obligated to undertake any action with respect to a registered holder of Rights or other securities of the Company upon the

occurrence of any purported transfer or exercise as set forth in this Section 7 unless such registered holder shall have (i) properly

completed and duly executed the certificate contained in the appropriate form of election to purchase set forth on the reverse side of

the Right Certificate surrendered for such exercise and (ii) provided such additional evidence of the identity of the Beneficial

Owner (or former Beneficial Owner) or Affiliates or Associates thereof, as the Company and the Rights Agent shall reasonably request.

Section 8.

Cancellation and Destruction of Right Certificates. All Right Certificates surrendered for the purpose of exercise, transfer,

split-up, combination or exchange shall, if surrendered to the Company or to any of its agents (other than the Rights Agent), be delivered

to the Rights Agent for cancellation or in canceled form, or, if surrendered to the Rights Agent, shall be canceled by it, and no Right

Certificates shall be issued in lieu thereof except as expressly permitted by any of the provisions of this Agreement. The Company shall

deliver to the Rights Agent for cancellation and retirement, and the Rights Agent shall so cancel and retire, any other Right Certificate

purchased or acquired by the Company otherwise than upon the exercise thereof. At the expense of the Company, the Rights Agent shall

deliver all canceled Right Certificates which have been canceled by the Rights Agent to the Company, or shall, at the written request

of the Company, destroy or cause to be destroyed such canceled Right Certificates, and in such case shall deliver a certificate of destruction

thereof to the Company.

Section 9.

Status and Availability of Preferred Shares.

9.1

The Company covenants and agrees that it will cause to be reserved and kept available, out of its authorized and unissued

Preferred Shares or any Preferred Shares held in its treasury, the number of Preferred Shares that will be sufficient to permit the exercise

in full of all outstanding Rights in accordance with Section 7.

9.2

The Company covenants and agrees that it will take all such action as may be necessary to ensure that all Preferred Shares

delivered upon exercise of Rights shall, at the time of delivery of the certificates (or entry in the book-entry account system of the

Company) for such Preferred Shares (subject to payment of the Purchase Price and compliance with all other applicable provisions of this

Agreement), be duly and validly authorized and issued and fully paid and non-assessable shares.

9.3              The

Company further covenants and agrees that it will pay when due and payable any and all federal and state transfer taxes and governmental

charges which may be payable in respect of the issuance or delivery of the Right Certificates or of any Preferred Shares upon the exercise

of Rights. The Company shall not, however, be required to pay any transfer tax or governmental charge which may be payable in respect

of any transfer or delivery of Right Certificates to a Person other than, or the issuance or delivery of certificates or depositary receipts

for Preferred Shares upon the exercise of any Rights until any such transfer tax or governmental charge shall have been paid (any such

transfer tax or governmental charge being payable by the holder of such Right Certificate at the time of surrender) or until it has been

established to the Company’s and the Rights Agent’s reasonable satisfaction that no such transfer tax or governmental charge

is due.

- 12 -

Section 10.

Preferred Shares Record Date. Each Person in whose name any certificate (or entry in the book-entry account system of the

Company) for Preferred Shares is issued upon the exercise of Rights shall for all purposes be deemed to have become the holder of record

of the Preferred Shares represented thereby on, and such certificate or book-entry shall be dated, the date upon which the Right Certificate

evidencing such Rights was duly surrendered and payment of the Purchase Price (and any applicable transfer taxes and governmental charges)

was made; provided that, if the date of such surrender and payment is a date upon which the Preferred Shares transfer books of

the Company are closed, such Person shall be deemed to have become the record holder of such shares on, and such certificate shall be

dated, the next succeeding Business Day on which the Preferred Shares transfer books of the Company are open. Prior to the exercise of

the Rights evidenced thereby, the holder of a Right Certificate shall not be entitled to any rights of a holder of Preferred Shares for

which the Rights shall be exercisable, including the right to vote, to receive dividends or other distributions, or to exercise any preemptive

rights, and shall not be entitled to receive any notice of any proceedings of the Company, except as provided herein.

Section 11.

Adjustment of Purchase Price, Number of Shares or Number of Rights.

11.1

General.

11.1.1

In the event that the Company shall at any time after the date of this Agreement (i) declare a dividend on the Preferred

Shares payable in Preferred Shares, (ii) subdivide the outstanding Preferred Shares, (iii) combine the outstanding Preferred

Shares into a smaller number of Preferred Shares or (iv) issue any shares of its capital stock in a reclassification of the Preferred

Shares (including any such reclassification in connection with a consolidation or merger in which the Company is the continuing or surviving

Person), except as otherwise provided in this Section 11.1, the Purchase Price in effect at the time of the record date for such

dividend or of the effective date of such subdivision, combination or reclassification, and the number and kind of shares of capital

stock issuable on such date, shall be proportionately adjusted so that the holder of any Right exercised after such time shall be entitled

to receive the aggregate number and kind of shares of capital stock which, if such Right had been exercised immediately prior to such

date, the holder would have owned upon such exercise and been entitled to receive by virtue of such dividend, subdivision, combination

or reclassification; provided that in no event shall the consideration to be paid upon the exercise of one Right be less than

the aggregate par value of the Preferred Shares issuable upon exercise of one Right. If an event occurs that would require an adjustment

under both this Section 11.1.1 and Section 11.1.2 hereof, the adjustment provided for in this Section 11.1.1 shall be in addition

to, and shall be made prior to, the adjustment required pursuant to Section 11.1.2 hereof.

11.1.2

Subject to the second paragraph of this Section 11.1.2 and

to Section 24, from and after the Stock Acquisition Date, each holder of a Right shall have a right to receive, upon exercise of each

Right at a price equal to the then current Purchase Price multiplied by the number of one one-thousandths of a Preferred Share for which

a Right is then exercisable, in accordance with the terms of this Agreement and in lieu of Preferred Shares, such number of Common Shares

as shall equal the result obtained by dividing (i) the product of (A) the current Purchase Price and (B) the number of one one-thousandths

of a Preferred Share for which a Right is then exercisable by (ii) 50% of the then Current Per Share Market Price of the Company’s

Common Shares (determined pursuant to Section 11.4) on the Stock Acquisition Date.

- 13 -

From and after the Stock

Acquisition Date, any Rights that are or were acquired or Beneficially Owned by (i) an Acquiring Person (or any Associate or Affiliate

of such Acquiring Person), (ii) a transferee of any Acquiring Person (or of any such Associate or Affiliate) who becomes such a transferee

after the Acquiring Person becomes an Acquiring Person or (iii) a transferee of an Acquiring Person (or of any such Associate or Affiliate)

who becomes such a transferee prior to or concurrently with the Acquiring Person becoming an Acquiring Person and who receives such Rights

(A) with actual knowledge that the transferor is or was an Acquiring Person or (B) pursuant to either (x) a transfer (whether or not

for consideration) from the Acquiring Person (or any such Associate or Affiliate) to holders of equity interests in such Acquiring Person

(or any such Associate or Affiliate) or to any Person with whom the Acquiring Person (or such Associate or Affiliate) has any continuing

agreement, arrangement, understanding or relationship (whether or not in writing) regarding the transferred Rights or (y) a transfer

which the Board of Directors has determined is part of a plan, arrangement or understanding (whether or not in writing) which has as

a primary purpose or effect of the avoidance of this Section 11.1.2, (each such Person described in (i)-(iii) above, an “Excluded

Person”) shall, in each such case, be null and void, and any holder of such Rights (whether or not such holder is an Acquiring

Person or an Associate or Affiliate of an Acquiring Person) shall thereafter have no right to exercise such Rights under any provision

of this Agreement. No Right Certificates shall be issued pursuant to Section 3, Section 6, Section 7.4 or Section 11 or otherwise hereof

that represents Rights that are or have become null and void pursuant to the provisions of this paragraph and any Right Certificate delivered

to the Rights Agent that represents Rights that are or have become null and void pursuant to the provisions of this paragraph shall,

upon receipt of written notice directing it to do so, be canceled by the Rights Agent.

11.1.3

If there are not sufficient authorized but unissued Common Shares to permit the exercise in full of the Rights in accordance

with Section 11.1.2 or the exchange of the Rights in accordance with Section 24, or should the Board of Directors so elect, the

Company may with respect to such deficiency, (i) determine the excess (the “Spread”) of (A) the value of

the Common Shares issuable upon the exercise of a Right as provided in Section 11.1.2 (the “Current Value”) over

(B) the Purchase Price, and (ii) with respect to each Right, make adequate provision to substitute for such Common Shares,

upon payment of the applicable Purchase Price, any one or more of the following having an aggregate value determined by the Board of

Directors to be equal to the Current Value: (A) cash, (B) a reduction in the Purchase Price, (C) Common Shares or other

equity securities of the Company (including shares, or units of shares, of preferred stock which the Board of Directors has determined

to have the same value as Common Shares (“Common Stock Equivalents”)), (D) debt securities of the Company or

(E) other assets, property or instruments. The Company shall provide the Rights Agent with prompt reasonably detailed written notice

of any final determination under the previous sentence.

- 14 -

If the Board of Directors

shall determine in good faith that additional Common Shares should be authorized for issuance upon exercise in full of the Rights, the

Company may suspend the exercisability of the Rights in order to seek any authorization of additional shares, decide the appropriate

form of distribution to be made, and determine the value thereof. If the exercisability of the Rights is suspended pursuant to this Section 11.1.3,

the Company shall make a public announcement, and shall promptly deliver to the Rights Agent a written statement, stating that the exercisability

of the Rights has been temporarily suspended. When the suspension is no longer in effect, the Company shall make another public announcement,

and promptly deliver to the Rights Agent a written statement, so stating. For purposes of this Section 11.1.3, the value of the

Common Shares shall be the Current Per Share Market Price of the Common Shares (as determined pursuant to Section 11.4.1) as of

the Stock Acquisition Date, and the value of any Common Stock Equivalent shall be deemed to have the same value as the Common Shares

on such date.

11.2

If the Company fixes a record date for the issuance of rights, options or warrants to all holders of Preferred Shares entitling

them (for a period expiring within 45 days after such record date) to subscribe for or purchase Preferred Shares (or shares having the

same rights, privileges and preferences as the Preferred Shares (“Equivalent Preferred Shares”)) or securities convertible

into Preferred Shares or Equivalent Preferred Shares at a price per Preferred Share or Equivalent Preferred Share (or having a conversion

price per share, if a security convertible into Preferred Shares or Equivalent Preferred Shares) less than the then Current Per Share

Market Price of the Preferred Shares (as determined pursuant to Section 11.4.2) on such record date, the Purchase Price to be in

effect after such record date shall be adjusted by multiplying the Purchase Price in effect immediately prior to such record date by

a fraction, (i) the numerator of which shall be (A) the number of Preferred Shares outstanding on such record date plus (B) the

number of Preferred Shares which the aggregate offering price of the total number of Preferred Shares or Equivalent Preferred Shares

to be offered (or the aggregate initial conversion price of the convertible securities to be offered) would purchase at such Current

Per Share Market Price and (ii) the denominator of which shall be (A) the number of Preferred Shares outstanding on such record date

plus (B) the number of additional Preferred Shares or Equivalent Preferred Shares to be offered for subscription or purchase (or into

which the convertible securities to be offered are initially convertible); provided that in no event shall the consideration to

be paid upon the exercise of one Right be less than the aggregate par value of the shares of capital stock of the Company issuable upon

exercise of one Right. If such subscription price may be paid in a consideration part or all of which shall be in a form other than cash,

the value of such consideration shall be as determined in good faith by the Board of Directors, whose determination shall be described

in a statement filed with the Rights Agent and shall be conclusive for all purposes. Preferred Shares owned by or held for the account

of the Company shall not be deemed outstanding for the purpose of any such computation. Such adjustment shall be made successively whenever

such a record date is fixed. If such rights, options or warrants are not so issued, the Purchase Price shall be adjusted to be the Purchase

Price that would then be in effect if such record date had not been fixed.

11.3

If the Company fixes a record date for the making of a distribution to all holders of the Preferred Shares (including any

distribution made in connection with a consolidation or merger in which the Company is the continuing or surviving Person) or evidences

of indebtedness or assets (other than a regular quarterly cash dividend or a dividend payable in Preferred Shares) or subscription rights

or warrants (excluding those referred to in Section 11.2), the Purchase Price to be in effect after such record date shall be determined

by multiplying the Purchase Price in effect immediately prior to such record date by a fraction, (i) the numerator of which shall be

the then Current Per Share Market Price of the Preferred Shares (as determined pursuant to Section 11.4.2) on such record date, less

the fair market value (as determined in good faith by the Board of Directors, whose determination shall be described in a statement filed

with the Rights Agent and shall be conclusive for all purposes) of the portion of the assets or evidences of indebtedness to be distributed

or of such subscription rights or warrants applicable to one Preferred Share and (ii) the denominator of which shall be the then Current

Per Share Market Price of the Preferred Shares (as determined pursuant to Section 11.4.2); provided that in no event shall the

consideration to be paid upon the exercise of one Right be less than the aggregate par value of the Preferred Shares to be issued upon

exercise of one Right. Such adjustments shall be made successively whenever such a record date is fixed. If such distribution is not

so made, the Purchase Price shall again be adjusted to be the Purchase Price that would then be in effect if such record date had not

been fixed.

- 15 -

11.4

Current Per Share Market Price.

11.4.1

For the purpose of any computation hereunder, the “Current Per Share Market Price” of any security on any

date shall be deemed to be the average of the daily closing prices per share of such security for the 30 consecutive Trading Days immediately

prior to such date; provided that if the Current Per Share Market Price of the security is determined during a period (i) following

the announcement by the issuer of such security of (A) a dividend or distribution on such security payable in shares of such security

or other securities convertible into such shares, or (B) any subdivision, combination or reclassification of such security, and

(ii) prior to the expiration of 30 Trading Days after the ex-dividend date for such dividend or distribution, or the record date for

such subdivision, combination or reclassification, then, and in each such case, the Current Per Share Market Price shall be appropriately

adjusted to reflect the current market price per share equivalent of such security. The closing price for each day shall be the last

sale price or, if no such sale takes place on such day, the average of the closing bid and asked prices, in either case as reported by

NYSE, or, if on any such date the security is not quoted by NYSE, the average of the closing bid and asked prices as furnished by a professional

market maker making a market in the security selected by the Board of Directors. If on any such date no such market maker is making a

market in the security, the fair value of the security on such date as determined in good faith by the Board of Directors shall be used.

11.4.2

For the purpose of any computation hereunder, the “Current Per Share Market Price” of the Preferred Shares

shall be determined in accordance with the method set forth in Section 11.4.1. If the Preferred Shares are not publicly traded,

the “Current Per Share Market Price” of the Preferred Shares shall be conclusively deemed to be the Current Per Share

Market Price of the Common Shares as determined pursuant to Section 11.4.1 (appropriately adjusted to reflect any stock split, stock

dividend or similar transaction occurring after the date hereof) multiplied by one thousand. If neither the Common Shares nor the Preferred

Shares are publicly held or so listed or traded, “Current Per Share Market Price” means the fair value per share as

determined in good faith by the Board of Directors, whose determination shall be described in a statement filed with the Rights Agent

and shall be conclusive for all purposes.

11.5

No adjustment in the Purchase Price shall be required unless such adjustment would require an increase or decrease of at least

1% in the Purchase Price; provided that any adjustments which by reason of this Section 11.5 are not required to be made

shall be carried forward and taken into account in any subsequent adjustment. All calculations under this Section 11 shall be made to

the nearest cent or to the nearest one one-thousandth of a Preferred Share or one one-thousandth of any other share or security, as the

case may be. Notwithstanding the first sentence of this Section 11.5, any adjustment required by this Section 11 shall be made no

later than three years from the date of the transaction which requires such adjustment.

- 16 -

11.6

If, as a result of an adjustment made pursuant to Section 11.1, the holder of any Right thereafter exercised shall become

entitled to receive any shares of capital stock of the Company other than Preferred Shares, the number of such other shares so receivable

upon exercise of any Right shall thereafter be subject to adjustment from time to time in a manner and on terms as nearly equivalent

as practicable to the provisions with respect to the Preferred Shares contained in Sections 11.1 through 11.3, inclusive, and

the provisions of Section 7, Section 9 and Section 10 with respect to the Preferred Shares shall apply on like terms to any such other

shares.

11.7

All Rights originally issued by the Company subsequent to any adjustment made to the Purchase Price hereunder shall evidence

the right to purchase, at the adjusted Purchase Price, the number of Preferred Shares purchasable from time to time hereunder upon exercise

of the Rights, all subject to further adjustment as provided herein.

11.8

Unless the Company exercises its election as provided in Section 11.9, upon each adjustment of the Purchase Price as

a result of the calculations made in Sections 11.2 and 11.3, each Right outstanding immediately prior to the making of such

adjustment shall thereafter evidence the right to purchase, at the adjusted Purchase Price, that number of one one-thousandth of a Preferred

Share (calculated to the nearest one one-thousandth of a Preferred Share) obtained by (i) multiplying the number of one one-thousandth

of a Preferred Share covered by a Right immediately prior to this adjustment by the Purchase Price in effect immediately prior to

such adjustment of the Purchase Price and (ii) dividing the product so obtained by the Purchase Price in effect immediately after

such adjustment of the Purchase Price.

11.9

The Company may elect on or after the date of any adjustment of the Purchase Price to adjust the number of Rights in substitution

for any adjustment in the number of Preferred Shares purchasable upon the exercise of a Right. Each of the Rights outstanding after such

adjustment of the number of Rights shall be exercisable for the number of Preferred Shares for which a Right was exercisable immediately

prior to such adjustment. Each Right held of record prior to such adjustment of the number of Rights shall become that number of Rights

(calculated to the nearest one one-thousandth) obtained by dividing the Purchase Price in effect immediately prior to adjustment of the

Purchase Price by the Purchase Price in effect immediately after adjustment of the Purchase Price. The Company shall make a public announcement

(with prompt written notice thereof to the Rights Agent) of its election to adjust the number of Rights, indicating the record date for

the adjustment and, if known at the time, the amount of the adjustment to be made. The record date may be the date on which the Purchase

Price is adjusted or any day thereafter but, if the Right Certificates have been distributed, shall be at least ten days after the date

of the public announcement. If Right Certificates have been distributed, upon each adjustment of the number of Rights pursuant to this

Section 11.9, the Company shall, as promptly as practicable, cause to be distributed to holders of record of Right Certificates

on such record date Right Certificates evidencing, subject to Section 14, the additional Rights to which such holders shall be entitled

as a result of such adjustment or, at the option of the Company, shall cause to be distributed to such holders of record in substitution

and replacement for the Right Certificates held by such holders prior to the date of adjustment, and upon surrender thereof if required

by the Company, new Right Certificates evidencing all the Rights to which such holders shall be entitled after such adjustment. Right

Certificates to be so distributed shall be issued, executed and countersigned in the manner provided for herein and shall be registered

in the names of the holders of record of Right Certificates on the record date specified in the public announcement.

- 17 -

11.10

Irrespective of any adjustment or change in the Purchase Price or the number of Preferred Shares issuable upon the exercise

of the Rights, the Right Certificates theretofore and thereafter issued may continue to express the Purchase Price and the number of

Preferred Shares which were expressed in the initial Right Certificates issued hereunder.

11.11

Before taking any action that would cause an adjustment reducing the Purchase Price below the then par value of the Preferred

Shares issuable upon exercise of the Rights, the Company shall take any corporate action which may, in the opinion of its counsel, be

necessary in order that the Company may validly and legally issue fully paid and non-assessable Preferred Shares at such adjusted Purchase

Price.

11.12

If this Section 11 requires that an adjustment in the Purchase Price be made effective as of a record date for a specified

event, the Company may defer, until the occurrence of such event, issuing to the holder of any Right exercised after such record date

Preferred Shares and other capital stock or securities of the Company, if any, issuable upon such exercise over and above the Preferred

Shares and other capital stock or securities of the Company, if any, issuable upon such exercise on the basis of the Purchase Price in

effect prior to such adjustment; provided that the Company shall deliver to such holder a due bill or other appropriate instrument

evidencing such holder’s right to receive such additional shares upon the occurrence of the event requiring adjustment.

11.13

Anything in this Section 11 to the contrary notwithstanding, the Company shall be entitled to make such reductions in the

Purchase Price, in addition to those adjustments expressly required by this Section 11, as and to the extent that it in its sole discretion

shall determine to be advisable in order that any (i) combination or subdivision of the Preferred Shares, (ii) issuance wholly

for cash of any Preferred Shares at less than the Current Per Share Market Price, (iii) issuance wholly for cash of Preferred Shares

or securities which by their terms are convertible into or exchangeable for Preferred Shares, (iv) dividends on Preferred Shares

payable in Preferred Shares, or (v) issuance of any rights, options or warrants referred to in Section 11.2 made by the Company

after the date of this Agreement to holders of its Preferred Shares shall not be taxable to such shareholders.

11.14

If, at any time after the date of this Agreement and prior to the Distribution Date, the Company (i) declares or pays

any dividend on the Common Shares payable in Common Shares or (ii) effects a subdivision, combination or consolidation of the Common

Shares (by reclassification or otherwise other than by payment of dividends in Common Shares) into a greater or lesser number of Common

Shares, then in any such case (A) the number of one one-thousandths of a Preferred Share purchasable after such event upon exercise

of each Right shall be determined by multiplying the number of one one-thousandths of a Preferred Share so purchasable immediately prior

to such event by a fraction, the numerator of which is the number of Common Shares outstanding immediately before such event and the

denominator of which is the number of Common Shares outstanding immediately after such event, and (B) each Common Share outstanding

immediately after such event shall have issued with respect to it that number of Rights which each Common Share outstanding immediately

prior to such event had issued with respect to it. The adjustments provided for in this Section 11.14 shall be made successively

whenever such a dividend is declared or paid or such a subdivision, combination or consolidation is affected.

- 18 -

Section 12.

Certificate of Adjustment. Whenever an adjustment or any event affecting the Rights or their exercisability (including an

event that causes Rights to become null and void) occurs or is made as provided in Section 11, the Company shall promptly (i) prepare

a certificate setting forth such adjustment and a reasonably detailed statement of the facts, computations, methodology and accounting

for such adjustment, (ii) file with the Rights Agent and with each transfer agent for the Common Shares or the Preferred Shares a copy

of such certificate, and (iii) if such adjustment occurs following a Distribution Date, mail a brief summary thereof to each holder

of a Right Certificate in accordance with Section 25. The Rights Agent shall be fully protected in relying on any such certificate and

on any adjustment or statement therein contained and shall not be obligated or responsible for calculating any adjustment, nor shall

the Rights Agent be deemed to have knowledge of such an adjustment or any such event, unless and until it shall have received such certificate.

Notwithstanding the foregoing sentence, but without limiting any of the rights or immunities of the Rights Agent, the failure of the

Company to make such certification or give such notice shall not affect the validity of, or the force or effect of, the requirement for

such adjustment. Any adjustment to be made pursuant to Section 11 hereof shall be effective as of the date of the event giving rise to

such adjustment. The Rights Agent shall be fully protected in relying, in the absence of bad faith on its part, on any such certificate

and on any adjustment or statement therein and shall have no duty or liability with respect thereto, and shall not be deemed to have

knowledge of any such adjustment or any such event unless and until it shall have received such certificate.

Section 13.

[Reserved].

Section 14.

Fractional Rights and Fractional Shares.

14.1

The Company shall not be required to issue fractions of Rights or to distribute Right Certificates which evidence fractional

Rights. In lieu of such fractional Rights, the Company may instead pay to the registered holders of the Right Certificates with regard

to which such fractional Rights would otherwise be issuable an amount in cash equal to the same fraction of the current market value

of a whole Right. For the purposes of this Section 14.1, the current market value of a whole Right shall be the closing price of

the Rights (as determined pursuant to the second sentence of Section 11.4.1) for the Trading Day immediately prior to the date on

which such fractional Rights would have been otherwise issuable.

14.2

The Company shall not be required to issue fractions of Preferred Shares (other than fractions which are integral multiples

of one one-thousandth of a Preferred Share) upon exercise of the Rights, to distribute certificates which evidence fractional Preferred

Shares or to register fractional Preferred Shares in the Company’s share register (other than fractions which are integral multiples

of one one-thousandth of a Preferred Share). Fractions of Preferred Shares in integral multiples of one one-thousandth of a Preferred

Share may, at the election of the Company, be evidenced by depositary receipts, pursuant to an agreement between the Company and a depositary

selected by the Company; provided that such agreement shall provide that the holders of such depositary receipts shall have all

the rights, privileges and preferences to which they are entitled as Beneficial Owners of the Preferred Shares represented by such depositary

receipts. In lieu of fractional Preferred Shares that are not integral multiples of one one-thousandth of a Preferred Share, the Company

shall pay to each registered holder of Right Certificates at the time such Rights are exercised as herein provided an amount in cash

equal to the same fraction of the current market value of one Preferred Share as the fraction of one Preferred Share that such holder

would otherwise receive upon the exercise of the aggregate number of rights exercised by such holder. For the purposes of this Section 14.2,

the current market value of a Preferred Share shall be the closing price of a Preferred Share (pursuant to Section 11.4.1) for the

Trading Day immediately prior to the date of such exercise.

- 19 -

14.3

For purposes of this Section 14, the closing price for any day shall be the last quoted price or, if not so quoted, the average

of the high bid and low asked prices as reported by NYSE, or if on any such date the Rights or Preferred Shares, as applicable, are not

listed on NYSE, the average of the closing bid and asked prices as furnished by a professional market maker making a market in the Rights

or Preferred Shares, as applicable, selected by the Board of Directors. If on any such date no such market maker is making a market in

the Rights or Preferred Shares, as applicable, the fair value of the Rights or Preferred Shares, as applicable, on such date as determined

in good faith by the Board of Directors shall be used.

14.4

The holder of a Right by the acceptance of the Right expressly waives any right to receive fractional Rights or fractional

shares upon exercise of a Right (except as provided in this Section 14).

14.5

Whenever a payment for fractional Rights or fractional shares is to be made by the Rights Agent under any section of this

Agreement, the Company shall (i) promptly prepare and deliver to the Rights Agent a certificate setting forth in reasonable detail the

facts related to such payments and the prices and formulas utilized in calculating such payments, and (ii) provide sufficient monies

to the Rights Agent in the form of fully collected funds to make such payments. The Rights Agent shall be fully protected in relying

upon such a certificate and shall have no duty with respect to, and shall not be deemed to have knowledge of, any payment for fractional

Rights or fractional shares under any section of this Agreement relating to the payment of fractional Rights or fractional shares unless

and until the Rights Agent shall have received such a certificate and sufficient monies.

Section 15.

Rights of Action. All rights of action in respect of this Agreement, excepting the rights of action vested in the Rights Agent

pursuant to the terms of this Agreement, are vested in the respective registered holders of the Right Certificates. Any registered holder

of any Right Certificate may, without the consent of the Rights Agent or of the holder of any other Right Certificate, on such holder’s

own behalf and for such holder’s own benefit, enforce, and may institute and maintain any suit, action or proceeding against the

Company to enforce, or otherwise act in respect of, such holder’s right to exercise the Rights evidenced by such Right Certificate

in the manner provided in such Right Certificate and in this Agreement. Without limiting the foregoing or any remedies available to the

holders of Rights, it is specifically acknowledged that the holders of Rights would not have an adequate remedy at law for any breach

of this Agreement by the Company and will be entitled to specific performance of the obligations hereunder, and injunctive relief against

actual or threatened violations of the obligations hereunder, of the Company.

- 20 -

Section 16.

Agreement of Right Holders. Every holder of a Right, by accepting the same, consents and agrees with the Company and the Rights

Agent and with every other holder of a Right that:

16.1

prior to the Distribution Date, the Rights will be transferable only in connection with the transfer of the Common Shares;

16.2

after the Distribution Date, the Right Certificates are transferable only on the registry books maintained by the Rights Agent

if surrendered at the office or offices of the Rights Agent designated for such purpose, duly endorsed or accompanied by a proper instrument

of transfer with the appropriate form of certification, properly completed and duly executed, accompanied by a Signature Guarantee and

such other documentation as the Rights Agent may reasonably request;

16.3

the Company and the Rights Agent may deem and treat the Person in whose name the Right Certificate (or, prior to the Distribution

Date, the associated Common Shares certificate or, in the case of uncertificated Common Shares, by the book-entry that evidences record

ownership of such Common Shares) is registered as the absolute owner thereof and of the Rights evidenced thereby (notwithstanding any

notations of ownership or writing on the Right Certificates or the associated Common Shares certificate or book-entry made by anyone

other than the Company or the Rights Agent) for all purposes whatsoever, and neither the Company nor the Rights Agent shall be affected

by any notice to the contrary; and

16.4

notwithstanding anything in this Agreement to the contrary, the Rights Agent shall not have any liability to any holder of

a Right or other Person as a result of the inability of the Company or the Rights Agent to perform any of its or their respective obligations

under this Agreement by reason of any preliminary or permanent injunction or other order, decree, judgment or ruling issued by a court

of competent jurisdiction or by a governmental, regulatory or administrative agency or commission, or any statute, rule, regulation or

executive order promulgated or enacted by any governmental authority prohibiting or otherwise restraining performance of such obligation.

Section 17.

Right Certificate Holder Not Deemed a Shareholder. No holder, as such, of any Right Certificate shall be entitled to vote

or receive dividends, or be deemed for any purpose the holder of the Preferred Shares or any other securities of the Company that may

at any time be issuable on the exercise or exchange of the Rights represented thereby, nor shall anything contained herein or in any

Right Certificate be construed to confer upon the holder of any Right Certificate, as such, any of the rights of a shareholder of the

Company or any right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, to give

or withhold consent to any corporate action, to receive notice of meetings or other actions affecting shareholder (except as provided

in Section 25), or to receive dividends or subscription rights, or otherwise, until the Rights evidenced by such Right Certificate shall

have been exercised or exchanged in accordance with the provisions hereof.

- 21 -

Section 18.

Concerning the Rights Agent. The Company agrees to pay to the Rights Agent reasonable compensation for all services rendered

by it hereunder in accordance with a fee schedule to be mutually agreed upon, and, from time to time, on demand of the Rights Agent,

to reimburse the Rights Agent for all of its reasonable expenses and counsel fees and other disbursements incurred in the preparation,

delivery, negotiation, administration, execution and amendment, of this Agreement and the exercise and performance of its duties hereunder.

The Company also covenants and agrees to indemnify the Rights Agent for, and to hold it harmless against, any and all loss, liability,

damage, judgment, fine, penalty, claim, demand, settlement, cost or expense (including the reasonable fees and expenses of legal counsel)

that may be paid, incurred or suffered by it, or to which it may become subject, without gross negligence, bad faith or willful misconduct

on the part of the Rights Agent (which gross negligence, bad faith or willful misconduct must be determined by a final, non-appealable

judgment of a court of competent jurisdiction), for any action taken, suffered or omitted to be taken by the Rights Agent in connection

with the execution, acceptance, administration of, exercise and performance of its duties under this Agreement, including the costs and

expenses of defending against any claim or liability arising therefrom or in connection therewith, directly or indirectly, or of enforcing

its rights hereunder. The provisions under this Section 18 and Section 20 below shall survive the exercise, termination and expiration

of the Rights and the termination of this Agreement and the resignation, replacement or removal of the Rights Agent. The reasonable costs

and expenses incurred in enforcing this right of indemnification shall be paid by the Company.

The Rights Agent shall be

fully authorized and protected and shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by

it in connection with its acceptance and administration of this Agreement and the exercise and performance of its duties hereunder, in

each case in reliance upon any Right Certificate or certificate for Preferred Shares or for other securities of the Company, instrument

of assignment or transfer, power of attorney, endorsement, affidavit, letter, notice, instruction, direction, consent, certificate, statement,

or other paper or document believed by it to be genuine and to be signed, executed and, where necessary, guaranteed, verified or acknowledged

by the proper Person or Persons, or otherwise upon the advice of counsel as set forth in Section 20. The Rights Agent shall not be deemed

to have knowledge of any event of which it was supposed to receive notice thereof hereunder, and the Rights Agent shall be fully protected

and shall incur no liability for failing to take action in connection therewith, unless and until it has received such notice in writing.

Notwithstanding anything

in this Agreement to the contrary, in no event will the Rights Agent be liable for special, punitive, indirect, incidental or consequential

loss or damage of any kind whatsoever (including lost profits), even if the Rights Agent has been advised of the likelihood of such loss

or damage and regardless of the form of action.

Section 19.

Merger or Consolidation or Change of Name of Rights Agent. Any Person into which the Rights Agent or any successor Rights

Agent may be merged or with which it may be consolidated, or any Person resulting from any merger or consolidation to which the Rights

Agent or any successor Rights Agent shall be a party, or any Person succeeding to the stock transfer or other shareholder services business

of the Rights Agent or any successor Rights Agent, shall be the successor to the Rights Agent under this Agreement without the execution

or filing of any paper or any further act on the part of any of the parties hereto; provided that such Person would be eligible

for appointment as a successor Rights Agent under the provisions of Section 21. The purchase of all or substantially all of the Rights

Agent’s assets employed in the performance of transfer agent activities shall be deemed a merger or consolidation for purposes

of this Section 19. If, at the time such successor Rights Agent shall succeed to the agency created by this Agreement, any of the Right

Certificates shall have been countersigned but not delivered, any such successor Rights Agent may adopt the countersignature of the predecessor

Rights Agent and deliver such Right Certificates so countersigned. If, at that time, any of the Right Certificates shall not have been

countersigned, any successor Rights Agent may countersign such Right Certificates either in the name of the predecessor Rights Agent

or in the name of the successor Rights Agent. In all such cases such Right Certificates shall have the full force provided in the Right

Certificates and in this Agreement.

- 22 -

If, at any time, the name

of the Rights Agent changes and any of the Right Certificates have been countersigned but not delivered, the Rights Agent may adopt the

countersignature under its prior name and deliver Right Certificates so countersigned. If, at that time, any of the Right Certificates

have not been countersigned, the Rights Agent may countersign such Right Certificates either in its prior name or in its changed name.

In all such cases such Right Certificates shall have the full force provided in the Right Certificates and in this Agreement.

Section 20.

Rights and Duties of Rights Agent.

20.1

The Rights Agent undertakes to perform only the duties and obligations expressly set forth in this Agreement and no implied

duties or obligations shall be read into this Agreement against the Rights Agent. The Rights Agent shall perform its duties and obligations

hereunder upon the following terms and conditions, by all of which the Company and the holders of Right Certificates, by their acceptance

thereof, shall be bound.

20.2

The Rights Agent may consult with legal counsel selected by it (who may be legal counsel for the Company or an employee or

legal counsel of the Rights Agent), and the advice or opinion of such counsel shall be full and complete authorization and protection

to the Rights Agent and the Rights Agent shall incur no liability for or in respect of any action taken or omitted by it in the absence

of bad faith and in accordance with such advice or opinion.

20.3

Whenever in the performance of its duties under this Agreement the Rights Agent shall deem it necessary or desirable that

any fact or matter (including the identity of any Acquiring Person and the determination of the Current Per Share Market Price) be proved

or established by the Company prior to taking, suffering or omitting to take any action hereunder, such fact or matter (unless other

evidence in respect thereof is specifically prescribed herein) may be deemed to be conclusively proved and established by a certificate

signed by a Person reasonably believed by the Rights Agent to be any two of the Chief Executive Officer, the Chairman of the Board of

Directors, the President, a Vice President, the Corporate Secretary or an Assistant Corporate Secretary of the Company and delivered

to the Rights Agent, and such certificate shall be full and complete authorization and protection to the Rights Agent and the Rights

Agent shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it under the provisions of this

Agreement in reliance upon such certificate. The Rights Agent shall have no duty to act without such a certificate as set forth in this

Section 20.3.

20.4

The Rights Agent shall be liable to the Company and any other Person hereunder only for its own gross negligence, bad faith

or willful misconduct (which gross negligence, bad faith or willful misconduct must be determined by a final, non-appealable judgment

of a court of competent jurisdiction). Notwithstanding anything in this Agreement to the contrary but subject to applicable law, any

liability of the Rights Agent under this Agreement will be limited to the amount of annual fees paid by the Company to the Rights Agent

(but not including reimbursable expenses) during the 12 months immediately preceding the event for which recovery from the Rights Agent

is being sought.

- 23 -

20.5

The Rights Agent shall not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement

or in the Right Certificates (except as to its countersignature thereof) or be required to verify the same. All such statements and recitals

are and shall be deemed to have been made by the Company only.

20.6

The Rights Agent shall not have any liability for or be under any responsibility in respect of the validity of this Agreement

or the execution and delivery hereof (except the due execution hereof by the Rights Agent) or in respect of the legality or validity

or execution of any Right Certificate (except its countersignature thereof); nor shall it be responsible for any determination by the

Board of Directors with respect to the Rights or breach by the Company of any covenant or failure by the Company to satisfy any condition

contained in this Agreement or in any Right Certificate; nor shall it be liable or responsible for any modification by or order of any

court, tribunal or governmental authority in connection with the foregoing, any change in the exercisability of the Rights or any adjustment

or calculation required under the provisions of Section 11 or for the manner, method or amount of any such adjustment or the ascertaining

of the existence of facts that would require any such adjustment or calculation (except with respect to the exercise of Rights evidenced

by Right Certificates after receipt of a certificate furnished pursuant to Section 12 describing such adjustment); nor shall it by any

act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Preferred Shares

to be issued pursuant to this Agreement or any Right Certificate or as to whether any Preferred Shares will, when so issued, be validly

authorized and issued, fully paid, and non-assessable.

20.7

The Rights Agent shall not be liable or responsible for any failure of the Company to comply with any of its obligations relating

to any registration statement filed with the Securities and Exchange Commission or this Agreement, including without limitation obligations

under applicable regulation or law.

20.8

The Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any holder

of Rights with respect to any action or default by the Company, including, without limiting the generality of the foregoing, any duty

or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon the Company.

20.9

The Company agrees that it will perform, execute, acknowledge and deliver, or cause to be performed, executed, acknowledged

and delivered, all such further and other acts, instruments and assurances as may reasonably be required or reasonably requested by the

Rights Agent for the carrying out or performing by the Rights Agent of the provisions of this Agreement.

- 24 -

20.10

The Rights Agent is hereby authorized and directed to accept written instructions with respect to the performance of its duties

hereunder and certificates delivered pursuant to any provision hereof from any Person reasonably believed by the Rights Agent to be any

one of the Chairman of the Board, the Chief Executive Officer, the President, a Vice President, the Corporate Secretary or an Assistant

Corporate Secretary of the Company, and to apply to such officers for advice or instructions in connection with its duties under this

Agreement, and such advice or instructions shall provide full authorization and protection to the Rights Agent, and the Rights Agent

shall not be liable for any action taken, suffered or omitted to be taken by it in accordance with the written advice or instructions

of any such officer or for any delay in acting while waiting for these instructions. Any application by the Rights Agent for written

instructions from the Company may, at the option of the Rights Agent, set forth in writing any action proposed to be taken, suffered

or omitted to be taken by the Rights Agent with respect to its duties or obligations under this Agreement, and the date on and/or after

which such action shall be taken or such omission shall be effective. The Rights Agent shall be fully authorized and protected in relying

upon the most recent advice or instructions received by any such officer, and shall not be liable for any action taken, suffered or omitted

to be taken by the Rights Agent in accordance with a proposal included in any such application on or after the date specified in such

application (which date shall not be less than five Business Days after the date any officer of the Company actually receives such application,

unless any such officer shall have consented in writing to an earlier date) unless, prior to taking any such action (or the effective

date, in the case of an omission), the Rights Agent has received written instructions in response to such application specifying the

action to be taken, suffered or omitted to be taken.

20.11

The Rights Agent and any affiliate, shareholder, director, officer, agent, representative or employee of the Rights Agent

may buy, sell or deal in any of the Rights or other securities of the Company, or become pecuniarily interested in any transaction in

which the Company may be interested, or contract with or lend money to the Company, or otherwise act as fully and freely as though it

were not the Rights Agent under this Agreement, in each case in compliance with applicable laws. Nothing herein shall preclude the Rights

Agent and such other Persons from acting in any other capacity for the Company or for any other legal entity.

20.12

The Rights Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either

itself or by or through its attorneys or agents. The Rights Agent shall not be answerable or accountable for any act, omission, default,

neglect, or misconduct of any such attorneys or agents or for any loss to the Company or any other Person resulting from any such act,

omission, default, neglect or misconduct, absent gross negligence or bad faith in the selection and continued employment of such attorneys

or agents thereof (which gross negligence or bad faith must be determined by a final, non-appealable judgment of a court of competent

jurisdiction).

20.13

No provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial

liability in the performance of any of its duties hereunder or in the exercise of its rights or powers if the Rights Agent believes that

repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured to it.

20.14

The Rights Agent shall not be required to take notice or be deemed to have notice of any fact, event, condition or determination

(including any dates or events defined in this Agreement or the designation of any Person as an Acquiring Person, Affiliate or Associate)

under this Agreement unless and until the Rights Agent shall be specifically notified in writing by the Company of such fact, event,

condition or determination, and all notices or other instruments required by this Agreement to be delivered to the Rights Agent must,

in order to be effective, be received by the Rights Agent as specified in Section 26, and in the absence of such notice so delivered,

the Rights Agent may conclusively assume no such event or condition exists.

- 25 -

20.15

The Rights Agent shall have no responsibility to the Company or any holders of the Right Certificates or any other Person

for interest or earnings on any moneys held by the Rights Agent pursuant to this Agreement.

20.16

If, with respect to any Rights Certificate surrendered to the Rights Agent for exercise or transfer, the certificate attached

to the form of assignment or form of election to purchase, as the case may be, has not been properly completed to certify the holder

is not an Acquiring Person or an Affiliate or Associate thereof, the Rights Agent shall not take any further action with respect to such

requested exercise or transfer without first consulting with the Company; provided, however that Rights Agent shall not be liable for

any delays arising from the duties under this Section 20.16.

20.17

The Rights Agent may rely on and be fully authorized and protected in acting or failing to act upon (a) Signature Guarantee,

or (b) any law, act, regulation or any interpretation of the same.

20.18

In the event the Rights Agent believes any ambiguity or uncertainty exists hereunder or in any notice, instruction, direction,

request or other communication, paper or document received by the Rights Agent hereunder, the Rights Agent, may (upon prompt notice to

the Company of such ambiguity or uncertainty), in its sole discretion, refrain from taking any action, and shall be fully protected and

shall not be liable in any way to the Company or the holder of any Rights Certificate or any other Person for refraining from taking

such action, unless the Rights Agent receives written instructions signed by the Company which eliminates such ambiguity or uncertainty

to the satisfaction of the Rights Agent.

Section 21.

Change of Rights Agent. The Rights Agent or any successor Rights Agent may resign and be discharged from its duties under

this Agreement upon 30 days’ notice in writing to the Company and, in the event that the Rights Agent or one of its Affiliates

is not also the transfer agent for the Company in accordance with Section 26 hereof, to each transfer agent of the Common Shares and

the Preferred Shares, if known to the Rights Agent, by first-class mail, postage prepaid. The Company may remove the Rights Agent or

any successor Rights Agent upon no less than 30 days’ notice in writing, mailed to the Rights Agent or successor Rights Agent in

accordance with Section 26 hereof, as the case may be, and to each transfer agent of the Common Shares and the Preferred Shares by registered

or certified mail, and, after the Distribution Date, to the holders of the Right Certificates by first-class mail. In the event that

the transfer agency relationship in effect between the Company and the Rights Agent terminates, the Rights Agent will be deemed to have

resigned automatically and be discharged from its duties as Rights Agent under this Agreement as of the effective date of such termination,

and the Company shall be responsible for sending any required notice. If the Rights Agent shall resign or be removed or shall otherwise

become incapable of acting, the Company shall appoint a successor to the Rights Agent. If the Company shall fail to make such appointment

within a period of 30 days after giving notice of such removal or after it has been notified in writing of such resignation or incapacity

by the resigning or incapacitated Rights Agent or by any registered holder of a Rights Certificate (who shall, with such notice, submit

such holder’s Rights Certificate for inspection by the Company), then the incumbent Rights Agent or registered holder of any Right

Certificate may apply to any court of competent jurisdiction for the appointment of a new Rights Agent. Any successor Rights Agent, whether

appointed by the Company or by such a court, shall be (i) a Person (other than a natural person) organized and doing business under the

laws of the United States or of any state of the United States, in good standing, which is authorized under such laws to exercise corporate

trust, stock transfer or shareholder services powers and is subject to supervision or examination by federal or state authority, and

which has, along with its Affiliates, at the time of its appointment as Rights Agent a combined capital and surplus of at least $50 million

or (ii) an Affiliate of a Person described in clause (i) of this sentence. After appointment, the successor Rights Agent shall be vested

with the same powers, rights, duties and responsibilities as if it had been originally named as Rights Agent under this Agreement without

further act or deed, and the predecessor Rights Agent shall deliver and transfer to the successor Rights Agent any property at the time

held by it hereunder, and shall execute and deliver any further reasonable assurance, conveyance, act or deed necessary for the purpose

but such predecessor Rights Agent shall not be required to make any additional expenditure or assume any additional liability in connection

with the foregoing, and shall thereafter be discharged from all duties and obligations hereunder. Not later than the effective date of

any such appointment the Company shall file notice thereof in writing with the predecessor Rights Agent and each transfer agent of the

Common Shares and the Preferred Shares, and, if such appointment occurs after the Distribution Date, mail a notice in writing to the

registered holders of the Right Certificates. Failure to give any notice provided for in this Section 21, however, or any defect therein,

shall not affect the legality or validity of the resignation or removal of the Rights Agent or the appointment of the successor Rights

Agent, as the case may be.

- 26 -

Section 22.

Issuance of New Right Certificates. Notwithstanding any of the provisions of this Agreement or of the Right Certificates to

the contrary, the Company may, at its option, issue new Right Certificates evidencing Rights in such form as may be approved by its Board

of Directors to reflect any adjustment or change in the Purchase Price and the number or kind or class of shares or other securities

or property purchasable under the Right Certificates made in accordance with the provisions of this Agreement. In addition, in connection

with the issuance or sale of Common Shares following the Distribution Date and prior to the earlier of the Redemption Date and the Final

Expiration Date, the Company may, with respect to Common Shares so issued or sold, issue Right Certificates representing the appropriate

number of Rights in connection with such issuance or sale; provided that no such Right Certificates may be issued if, and to the

extent that, the Board of Directors, in its sole discretion, determines that such issuance would jeopardize or endanger the value or

availability to the Company of the Tax Attributes or otherwise create a significant risk of material adverse tax consequences to the

Company.

Section 23.

Redemption.

23.1

The Board of Directors may, at its option, at any time prior to the earlier to occur of (i) the Close of Business on the tenth

day following the Stock Acquisition Date (or, if the tenth day following the Stock Acquisition Date occurs before the Record Date, the

Close of Business on the Record Date) and (ii) the Final Expiration Date, redeem all, but not less than all, of the then outstanding

Rights at a redemption price of $0.001 per Right, appropriately adjusted to reflect any stock split, stock dividend or similar transaction

occurring after the date hereof (the “Redemption Price”). The redemption of the Rights by the Board of Directors may

be made effective at such time, on such basis and subject to such conditions as the Board of Directors in its sole discretion may establish.

- 27 -

23.2

Immediately upon the time of the effectiveness of the redemption of the Rights or such earlier time as may be determined by

the Board of Directors in the action ordering such redemption (although not earlier than the time of such action) (the “Redemption

Date”), and without any further action and without any notice, the right to exercise the Rights shall terminate and the only

right thereafter of the holders of Rights shall be to receive the Redemption Price. The Company shall promptly give public notice of

any such redemption (with prompt written notice to the Rights Agent); provided that the failure to give, or any defect in, any

such notice shall not affect the validity of such redemption. Within ten Business Days after action of the Board of Directors ordering

the redemption of the Rights, the Company shall mail, or cause the Rights Agent to mail (at the expense of the Company), a notice of

redemption to the holders of the then outstanding Rights at their last addresses as they appear upon the registry books of the Rights

Agent or, prior to the Distribution Date, on the registry books of the transfer agent for the Common Shares. Any notice mailed in the

manner herein provided shall be deemed given, whether or not the holder receives the notice. If the payment of the Redemption Price is

not included with such notice, each such notice shall state the method by which the payment of the Redemption Price will be made. Neither

the Company nor any of its Affiliates or Associates may redeem, acquire or purchase for value any Rights at any time in any manner other

than that specifically set forth in this Section 23 or in Section 24, other than in connection with the purchase of Common Shares prior

to the Distribution Date.

Section 24.

Exchange.

24.1

The Board of Directors may, at its option, at any time after a Stock Acquisition Date, mandatorily exchange all or part of

the then outstanding and exercisable Rights (which excludes Rights that have become void pursuant to Section 11.1.2) for Common

Shares at an exchange ratio of one Common Share per one one-thousandth of a Preferred Share represented by a Right, appropriately adjusted

to reflect any stock split, stock dividend or similar transaction occurring after the date hereof (the “Exchange Ratio”).

The exchange of the Rights by the Board of Directors may be made effective at such time, on such basis and with such conditions as the

Board of Directors in its sole discretion may establish.

24.2

Immediately upon the action of the Board of Directors ordering the exchange of any Rights pursuant to Section 24.1, and

without any further action and without any notice, the right to exercise such Rights shall terminate and the only right thereafter of

a holder of such Rights shall be to receive that number of Common Shares equal to the number of such Rights held by such holder multiplied

by the Exchange Ratio. The Company shall promptly give reasonably detailed written notice of any such exchange to the Rights Agent, and

shall promptly give public notice of any such exchange; provided that the failure to give, or any defect in, any such notice shall

not affect the validity of such exchange. Within ten Business Days after action by the Board of Directors ordering the exchange of any

Rights pursuant to Section 24.1, the Company shall mail, or cause the Rights Agent to mail, a notice of any such exchange to the holders

of such Rights at their last addresses as they appear upon the registry books of the Rights Agent. Any notice mailed in the manner herein

provided shall be deemed given, whether or not the holder receives the notice. Each such notice of exchange will state the method by

which the exchange of the Common Shares for Rights will be effected and, in the event of any partial exchange, the number of Rights which

will be exchanged. Any partial exchange shall be effected pro rata based on the number of Rights (other than Rights which have

become void pursuant to the provisions of Section 11.1.2) held by each holder of Rights.

- 28 -

24.3

In any exchange pursuant to this Section 24, the Company, at its option, may substitute Preferred Shares or Common Stock Equivalents

for Common Shares exchangeable for Rights, at the initial rate of one one-thousandth of a Preferred Share (or an appropriate number of

Common Stock Equivalents) for each Common Share, as appropriately adjusted.

24.4

If there shall not be sufficient Common Shares, Preferred Shares or Common Stock Equivalents authorized but unissued to permit

any exchange of Rights as contemplated in accordance with this Section 24, the Company shall use its reasonable efforts to authorize

additional Common Shares, Preferred Shares or Common Stock Equivalents for issuance upon exchange of the Rights.

24.5

The Company shall not be required to issue fractions of Common Shares or to distribute certificates which evidence fractional

Common Shares. In lieu of issuing fractional Common Shares, the Company may instead pay to the registered holders of the Right Certificates

with regard to which such fractional Common Shares would otherwise be issuable an amount in cash equal to the same fraction of the current

per share market value of a whole Common Share. For the purposes of this Section 24.5, the current per share market value of a whole

Common Share shall be the closing price of a Common Share (as determined pursuant to the second sentence of Section 11.4.1) for

the Trading Day immediately prior to the date of exchange pursuant to this Section 24.

24.6

Notwithstanding anything in this Section 24 to the contrary, the exchange of the Rights may be made effective at such time,

on such basis and subject to such conditions as the Board of Directors in its sole discretion may establish. Without limiting the preceding

sentence, the Board of Directors may (i) in lieu of issuing Common Shares or any other securities contemplated by this Section 24 to

the Persons entitled thereto in connection with the exchange (such Persons, the “Exchange Recipients,” and such shares

and other securities, together with any dividends or distributions made on such shares or other securities, the “Exchange Property”)

issue, transfer or deposit the Exchange Property to or into a trust or other entity (the “Trust”) created upon such

terms as the Board of Directors may determine to hold all or a portion of the Exchange Property for the benefit of the Exchange Recipients,

(ii) permit the Trust to exercise all of the rights that a shareholder of record would possess with respect to any shares deposited in

the Trust and (iii) direct that all holders of Rights entitled to receive Exchange Property shall be entitled to receive such Exchange

Property only from the Trust and only upon compliance with the relevant terms and provisions of the Trust and subject to such conditions

as the Board of Directors in its sole discretion may establish. Prior to effecting an exchange of Rights, the Company may require (or

cause the trustee or other governing body of the Trust to require), as a condition thereof, that any Exchange Recipient provide evidence

that it is not an Acquiring Person, including evidence of the identity of the current or former Beneficial Owners thereof and their Affiliates

and Associates, or any other Excluded Person pursuant to Section 11.1.2. If any Person shall fail to comply with any request to provide

such evidence, the Company shall be entitled conclusively to deem the Rights held by such Person to be null and void pursuant to Section

11.1.2 and not transferable or exercisable or exchangeable in connection herewith. In the event that the Board of Directors determines,

before the Distribution Date, to effect an exchange, the Board of Directors may delay the occurrence of the Distribution Date to such

time as the Board of Directors deems advisable.

- 29 -

Section 25.

Notice of Certain Events.

25.1

If the Company shall after the Distribution Date propose (i) to pay any dividend payable in stock of any class to the

holders of its Preferred Shares or to make any other distribution to the holders of its Preferred Shares (other than a regular quarterly

cash dividend); (ii) to offer to the holders of its Preferred Shares rights or warrants to subscribe for or to purchase any additional

Preferred Shares or shares of stock of any class or any other securities, rights or options; (iii) to effect any reclassification

of its Preferred Shares (other than a reclassification involving only the subdivision of outstanding Preferred Shares); (iv) to

effect any consolidation or merger into or with any other Person, or to effect any sale or other transfer (or to permit one or more of

its Subsidiaries to effect any sale or other transfer), in one or more transactions, of 50% or more of the assets or of the Company and

its Subsidiaries (taken as a whole) to any other Person; (v) to effect the liquidation, dissolution or winding-up of the Company;

or (vi) to declare or pay any dividend on the Common Shares payable in Common Shares, or to effect a subdivision, combination or

consolidation of the Common Shares (by reclassification or otherwise than by payment of dividends in Common Shares), then, in each such

case, the Company shall give to each holder of a Right Certificate and the Rights Agent, in accordance with Section 26, a reasonably

detailed notice of such proposed action, which shall specify the record date for the purposes of such stock dividend, or distribution

of rights or warrants, or the date on which such reclassification, consolidation, merger, sale, transfer, liquidation, dissolution or

winding-up is to take place and the date of participation therein by the holders of the Common Shares or Preferred Shares or both, if

any such date is to be fixed, and such notice shall be so given in the case of any action covered by clause (i) or (ii) above

at least ten days prior to the record date for determining holders of the Preferred Shares for purposes of such action, and in the case

of any such other action, at least ten days prior to the date of the taking of such proposed action or the date of participation therein

by the holders of the Common Shares or Preferred Shares or both, whichever shall be the earlier.

25.2

The Company shall, as soon as practicable after a Stock Acquisition Date, give to the Rights Agent and each holder of a Right

Certificate, in accordance with Section 26, a notice that describes the transaction in which a Person became an Acquiring Person and

the consequences of the transaction to holders of Rights under Section 11.1.2.

- 30 -

Section 26.

Notices. Notices or demands authorized by this Agreement to be given or made by the Rights Agent or by the holder of any Right

Certificate to or on the Company shall be sufficiently given or made if in writing and when sent by overnight delivery service or first-class

mail, postage prepaid, properly addressed (until another address is filed in writing with the Rights Agent) as follows:

Accendra Health, Inc.

4435 Waterfront Drive, Suite 300

Glen Allen, Virginia 23060

Attention:  Corporate Secretary

Email:          heath.galloway@accendra.com

with copies (which shall not constitute notice) to:

Kirkland & Ellis LLP

601 Lexington Avenue

New York, New York 10022

Attention: Allie Wein; Dan Li

Email:          allie.wein@kirkland.com;

dan.li@kirkland.com

Subject to the provisions of Section 21, any

notice or demand authorized by this Agreement to be given or made by the Company or by the holder of any Right Certificate to or on the

Rights Agent shall be deemed given upon receipt and shall be sufficiently given or made if in writing when sent by overnight delivery

service or registered or certified mail properly addressed (until another address is filed in writing with the Company) as follows:

Computershare Trust Company, N.A.

150 Royall Street

Canton, Massachusetts 02021

Attention:  Sandra Moore, A.V.P., Relationship

Manager, Issuer Services

Email:          sandra.moore@computershare.com

Notices or demands authorized by this Agreement

to be given or made by the Company or the Rights Agent to the holder of any Right Certificate shall be sufficiently given or made if

in writing, when sent by first-class mail, postage prepaid, addressed to such holder at the address of such holder as shown on the registry

books of the Company.

Section 27.

Supplements and Amendments. The Company may from time to time, and the Rights Agent shall if the Company so directs in writing,

supplement or amend this Agreement without the approval of any holders of Right Certificates in order to cure any ambiguity, to correct

or supplement any provision contained herein which may be defective or inconsistent with any other provisions herein, or to make any

change to or delete any provision hereof or to adopt any other provisions with respect to the Rights which the Company may deem necessary

or desirable; provided that, at any time after the Close of Business on the tenth day following the Stock Acquisition Date (or,

if the tenth day following the Stock Acquisition Date occurs before the Record Date, the Close of Business on the Record Date), this

Agreement shall not be amended or supplemented in any manner which would adversely affect the interests of the holders of Rights (other

than an Acquiring Person and its Affiliates and Associates). For the avoidance of doubt, the Company shall be entitled to adopt and implement

such procedures and arrangements (including with third parties) as it may deem necessary or desirable to facilitate the exercise, exchange,

trading, issuance or distribution of the Rights (and Preferred Shares) as contemplated hereby and to ensure that an Excluded Person does

not obtain the benefits thereof, and amendments in respect of the foregoing shall not be deemed to adversely affect the interests of

the holders of Rights. Any supplement or amendment authorized by this Section 27 will be evidenced by a writing signed by the Company

and the Rights Agent, subject to written certification by any of the officers of the Company listed in Section 20.3 that any such supplement

or amendment complies with this Section 27. Notwithstanding anything in this Agreement to the contrary, the Rights Agent shall not be

required to execute any supplement or amendment to this Agreement that it has reasonably determined would adversely affect its own rights,

duties, obligations or immunities hereunder. No supplement or amendment to this Agreement shall be effective unless duly executed by

the Rights Agent.

- 31 -

Section 28.

Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Rights Agent shall

bind and inure to the benefit of their respective successors and assigns hereunder.

Section 29.

Benefits of this Agreement. Nothing in this Agreement shall be construed to give to any Person or entity other than the Company,

the Rights Agent and the registered holders of the Right Certificates any legal or equitable right, remedy or claim under this Agreement.

This Agreement shall be for the sole and exclusive benefit of the Company, the Rights Agent and the registered holders of the Right Certificates.

Section 30.

Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction

or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement

shall remain in full force and effect and shall in no way be affected, impaired or invalidated; provided that if such excluded

provision shall affect the rights, immunities, liabilities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled

to resign immediately upon written notice to the Company.

Section 31.

Governing Law. This Agreement and each Right Certificate issued hereunder shall be deemed to be a contract made under the

laws of the Commonwealth of Virginia and for all purposes shall be governed by and construed in accordance with the laws of the Commonwealth

of Virginia applicable to contracts to be made and performed entirely within the Commonwealth of Virginia; provided that all provisions

regarding the rights, duties, liabilities and obligations of the Rights Agent shall be governed by and construed in accordance with the

laws of the State of New York applicable to contracts made and to be performed entirely within the State of New York.

Section 32.

Counterparts. This Agreement may be executed in any number of counterparts, and each of such counterparts shall for all purposes

be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. A signature to this

Agreement transmitted electronically shall have the same authority, effect and enforceability as an original signature.

Section 33.               Descriptive

Headings and Construction. Descriptive headings of the sections of this Agreement are inserted for convenience only and shall not

control or affect the meaning or construction of any of the provisions hereof. In this Agreement, (i) the word “including”

(in its various forms) means “including, without limitation,” and (ii) the words “hereunder,” “hereof,”

“hereto” and words of similar import are references to this Agreement as a whole and not to any particular provision of this

Agreement.

Section 34.

Administration. Other than with respect to rights, duties, obligations and immunities of the Rights Agent, the Board of Directors

(or a duly authorized committee of the Board of Directors) shall have the exclusive power and authority to administer and interpret the

provisions of this Agreement and to exercise all rights and powers specifically granted to the Board of Directors or the Company or as

may be necessary or advisable in the administration of this Agreement. Without limiting any of rights and immunities of the Rights Agent,

all such actions, calculations, determinations and interpretations which are done or made by the Board of Directors (or a duly authorized

committee of the Board of Directors) in good faith shall be final, conclusive and binding on the Company, the Rights Agent, holders of

the Rights and all other parties. The Rights Agent is entitled always to assume that the Board of Directors (or a duly authorized committee

of the Board of Directors) acted in good faith and shall be fully protected and incur no liability in reliance thereon.

- 32 -

Section 35.

Force Majeure. Notwithstanding anything to the contrary contained herein, the Rights Agent shall not be liable for any delays

or failures in performance resulting from acts beyond its reasonable control including, but not limited to any, acts or provision or

any present or future law or regulation or governmental authority, any act of God, terrorist acts, epidemics, pandemics, shortage of

supply, work stoppage, breakdowns or malfunctions, accident or failure or interruptions or malfunction of any utilities, communications,

or computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or retrieval systems,

labor difficulties, riot, rebellion, insurrection, fire, earthquake, storm, flood, strike, war, civil or military disobedience or disorder,

or civil unrest, or similar occurrence.

Section 36.

Process to Seek Exemption. Any Person who desires to effect any acquisition of Common Shares that might, if consummated, result

in such Person Beneficially Owning 4.9% or more of the Common Shares then outstanding (such Person, a “Requesting Person”)

may request that the Board of Directors grant an exemption with respect to such acquisition under this Agreement so that such Person

would be deemed to be an Exempt Person for purposes of this Agreement (such request, an “Exemption Request”). An Exemption

Request shall be in proper form and shall be delivered by registered mail, return receipt requested, to the Secretary of the Company

at the principal executive office of the Company. The Exemption Request shall be deemed made upon receipt by the Secretary of the Company.

To be in proper form, an Exemption Request shall set forth (i) the name and address of the Requesting Person, (ii) the number and percentage

of Common Shares then Beneficially Owned by the Requesting Person, together with all Affiliates and Associates of the Requesting Person

and (iii) a reasonably detailed description of the transaction or transactions by which the Requesting Person would propose to acquire

Beneficial Ownership of Common Shares aggregating 4.9% or more of the Common Shares then outstanding and the maximum number and percentage

of Common Shares that the Requesting Person proposes to acquire. The Board of Directors shall endeavor to respond to an Exemption Request

within 20 Business Days after receipt of such Exemption Request; provided that the failure of the Board of Directors to make a

determination within 20 Business Days after receipt of an Exemption Request shall be deemed to constitute denial by the Board of Directors

of the Exemption Request. The Requesting Person shall respond promptly to reasonable and appropriate requests for additional information

from the Company or the Board of Directors and its advisors to assist the Board of Directors in making its determination. The Board of

Directors shall only grant an exemption in response to an Exemption Request if it receives, at the request of the Board of Directors,

a report from the Company’s advisors to the effect that the acquisition of Beneficial Ownership of Common Shares by the Requesting

Person does not create a significant risk of material adverse tax consequences to the Company or the Board of Directors otherwise determines

in its sole and absolute discretion that the exemption is in the best interests of the Company. Any exemption granted hereunder may be

granted in whole or in part, and may be subject to limitations or conditions (including a requirement that the Requesting Person agree

that it will not acquire Beneficial Ownership of Common Shares in excess of the maximum number and percentage of shares approved by the

Board of Directors), in each case as and to the extent the Board of Directors shall determine necessary or desirable to provide for the

protection of the Company’s Tax Attributes. Any Exemption Request may be submitted on a confidential basis and, except to the extent

required by applicable law, the Company shall maintain the confidentiality of such Exemption Request and the determination of the Board

of Directors with respect thereto, unless the information contained in the Exemption Request or the determination of the Board of Directors

with respect thereto otherwise becomes publicly available. The Exemption Request shall be considered and evaluated by the directors who

are independent of the Requesting Person and disinterested with respect to the Exemption Request and the action of a majority of such

directors shall be deemed to be the determination of the Board of Directors for purposes of such Exemption Request. The Company shall

notify the Rights Agent of any exemption granted under this Section 36.

[Signature Pages Follow]

- 33 -

The parties hereto have caused

this Agreement to be duly executed as of the day and year first above written.

ACCENDRA HEALTH, INC.

By:

/s/ Jonathan A. Leon

Name:

Jonathan A. Leon

Title:

Executive Vice President and Chief Financial Officer

[Signature Page to Section

382 Rights Agreement]

The parties hereto have caused

this Agreement to be duly executed as of the day and year first above written.

COMPUTERSHARE TRUST COMPANY, N.A.

By:

/s/ Eugene Leybovich

Name:

Eugene Leybovich

Title:

Senior Vice President, Client Management

[Signature Page to Section

382 Rights Agreement]

EXHIBIT A

FORM

ARTICLES OF AMENDMENT

TO THE AMENDED AND RESTATED

ARTICLES OF INCORPORATION OF

ACCENDRA HEALTH, INC.

The undersigned, on behalf of the corporation

set forth below, pursuant to Title 13.1, Chapter 9, Article 11 of the Code of Virginia, states as follows:

Name. The name of the

corporation is ACCENDRA HEALTH, INC.

Text of Amendment. The

Amended and Restated Articles of Incorporation of the Corporation (the “Articles of Incorporation”) are amended to

add the following to Part A of Article III (the “Amendment”):

7.       Series

C Cumulative Preferred Stock.

The shares of this series

shall be designated as Series C Cumulative Preferred Stock (the “Series C Cumulative Preferred Stock”), and the number

of shares constituting the Series C Cumulative Preferred Stock shall be 100,000. Such number of shares may be increased or decreased

by resolution of the Board of Directors; provided, that no decrease shall reduce the number of shares of Series C Cumulative Preferred

Stock to a number less than the number of shares then outstanding plus the number of shares reserved for issuance upon the exercise of

outstanding options, rights or warrants or upon the conversion of any outstanding securities issued by the Corporation convertible into

Series C Junior Cumulative Preferred Stock. The Series C Junior Cumulative Preferred Stock shall have the following preferences, limitations

and relative rights:

Section 1.      Dividends

and Distributions.

(A)          Subject

to the rights of the holders of any shares of any series of preferred stock, par value $100.00 per share, of the Corporation (the “Cumulative

Preferred Stock”) (or any other stock of the Corporation) ranking prior and superior to the Series C Cumulative Preferred Stock

with respect to dividends, the holders of shares of Series C Cumulative Preferred Stock shall be entitled to receive, when, as and if

declared by the Board of Directors out of funds legally available for the purpose, quarterly dividends payable in cash on the last day

of March, June, September and December in each year (each such date a “Quarterly Dividend Payment Date”), commencing

on the first Quarterly Dividend Payment Date after the first issuance of a share or fraction of a share of Series C Cumulative Preferred

Stock, in an amount (if any) per share (rounded to the nearest cent), subject to the provision for adjustment hereinafter set forth,

equal to 1,000 times the aggregate per share amount of all cash dividends or other distributions, and 1,000 times the aggregate per share

amount (payable in kind) of all non-cash dividends or other distributions, other than a dividend payable in shares of common stock, par

value $2.00 per share of the Corporation (the “Common Stock”) or a subdivision of the outstanding shares of Common

Stock (by reclassification or otherwise) declared on the Common Stock since the immediately preceding Quarterly Dividend Payment Date

or, with respect to the first Quarterly Dividend Payment Date, since the first issuance of any share or fraction of a share of Series

C Cumulative Preferred Stock. In the event that the Corporation shall at any time declare or pay any dividend on the Common Stock payable

in shares of Common Stock, or effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification

or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then

in each such case the amount to which holders of shares of Series C Cumulative Preferred Stock were entitled immediately prior to such

event under the preceding sentence shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of

shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock

that were outstanding immediately prior to such event.

(B)           The

Corporation shall declare a dividend or distribution on the Series C Cumulative Preferred Stock as provided in paragraph (A) of

this Section 1 immediately after it declares a dividend or distribution on the Common Stock (other than a dividend payable in shares

of Common Stock).

due pursuant to paragraph (A) of this Section 1 shall begin to accrue and be cumulative on outstanding shares of Series C Cumulative

Preferred Stock from the Quarterly Dividend Payment Date next preceding the date of issue of such shares, unless the date of issue of

such shares is prior to the record date for the first Quarterly Dividend Payment Date, in which case dividends on such shares shall begin

to accrue from the date of issue of such shares, or unless the date of issue is a Quarterly Dividend Payment Date or is a date after

the record date for the determination of holders of shares of Series C Cumulative Preferred Stock entitled to receive a quarterly dividend

and before such Quarterly Dividend Payment Date, in either of which events such dividends shall begin to accrue and be cumulative from

such Quarterly Dividend Payment Date. Accrued but unpaid dividends shall not bear interest. Dividends paid on the shares of Series C

Cumulative Preferred Stock in an amount less than the total amount of such dividends at the time accrued and payable on such shares shall

be allocated pro rata on a share-by-share basis among all such shares at the time outstanding. The Board of Directors may fix a record

date for the determination of holders of shares of Series C Cumulative Preferred Stock entitled to receive payment of a dividend or distribution

declared thereon, which record date shall be not more than 60 days prior to the date fixed for the payment thereof.

-A-2-

Section 2.      Voting

Rights. The holders of shares of Series C Junior Cumulative Preferred Stock shall have the following voting rights:

(A)          Subject

to the provision for adjustment hereinafter set forth, each share of Series C Cumulative Preferred Stock shall entitle the holder thereof

to 1,000 votes on all matters submitted to a vote of the shareholders of the Corporation. In the event that the Corporation shall

at any time declare or pay any dividend on the Common Stock payable in shares of Common Stock, or effect a subdivision or combination

or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares

of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case the number of votes per share to which

holders of shares of Series C Cumulative Preferred Stock were entitled immediately prior to such event shall be adjusted by multiplying

such number by a fraction, the numerator of which is the number of shares of Common Stock outstanding immediately after such event and

the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.

(B)           Except

as otherwise provided in the Articles of Incorporation, including any other Articles of Amendment creating a series of Cumulative Preferred

Stock or any similar stock, or by law, the holders of shares of Series C Cumulative Preferred Stock and the holders of shares of Common

Stock and any other capital stock of the Corporation having general voting rights shall vote together as one class on all matters submitted

to a vote of shareholders of the Corporation.

as set forth herein, or as otherwise required by law, holders of Series C Cumulative Preferred Stock shall have no special voting rights

and their consent shall not be required (except to the extent they are entitled to vote with holders of Common Stock as set forth herein)

for taking any corporate action.

Section 3.      Certain

Restrictions.

(A)          Whenever

quarterly dividends or other dividends or distributions payable on the Series C Cumulative Preferred Stock as provided in Section 1

are in arrears, thereafter and until all accrued and unpaid dividends and distributions, whether or not declared, on shares of Series

C Cumulative Preferred Stock outstanding shall have been paid in full, the Corporation shall not:

(i)      declare

or pay dividends, or make any other distributions, on any shares of stock ranking junior (either as to dividends or upon liquidation,

dissolution or winding-up) to the Series C Cumulative Preferred Stock;

(ii)      declare

or pay dividends, or make any other distributions, on any shares of stock ranking on a parity (either as to dividends or upon liquidation,

dissolution or winding-up) with the Series C Cumulative Preferred Stock, except dividends paid ratably on the Series C Cumulative Preferred

Stock and all such parity stock on which dividends are payable or in arrears in proportion to the total amounts to which the holders

of all such shares are then entitled; or

(iii)      redeem

or purchase or otherwise acquire for consideration shares of any stock ranking junior (either as to dividends or upon liquidation, dissolution

or winding-up) to the Series C Cumulative Preferred Stock, provided that the Corporation may at any time redeem, purchase or otherwise

acquire shares of any such junior stock in exchange for shares of any stock of the Corporation ranking junior (as to dividends and upon

dissolution, liquidation or winding-up) to the Series C Cumulative Preferred Stock.

(B)       The

Corporation shall not permit any subsidiary of the Corporation to purchase or otherwise acquire for consideration any shares of stock

of the Corporation unless the Corporation could, under paragraph (A) of this Section 3, purchase or otherwise acquire such

shares at such time and in such manner.

-A-3-

Section 4.      Reacquired

Shares. Any shares of Series C Cumulative Preferred Stock purchased or otherwise acquired by the Corporation in any manner whatsoever

shall be retired and canceled promptly after the acquisition thereof. The Corporation shall take all such actions as are necessary to

cause all such shares to become authorized but unissued shares of Cumulative Preferred Stock that may be reissued as part of a new series

of Cumulative Preferred Stock subject to the conditions and restrictions on issuance set forth herein or in the Articles of Incorporation,

including any Articles of Amendment creating a series of Cumulative Preferred Stock or any similar stock, or as otherwise required by

law.

Section 5.      Liquidation,

Dissolution or Winding-Up.

(A)          Upon

any liquidation, dissolution or winding-up of the Corporation, voluntary or otherwise, no distribution shall be made to the holders of

stock ranking junior (either as to dividends or upon liquidation, dissolution or winding-up) to the Series C Cumulative Preferred Stock

unless, prior thereto, the holders of Series C Cumulative Preferred Stock shall have received an amount per share (the “Series

C Liquidation Preference”) equal to an amount per share, subject to the provision for adjustment hereinafter set forth, equal

to 1,000 times the aggregate amount to be distributed per share to holders of shares of Common Stock plus an amount equal to any

accrued and unpaid dividends. In the event that the Corporation shall at any time declare or pay any dividend on the Common Stock payable

in shares of Common Stock, or effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification

or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then

in each such case the aggregate amount to which holders of shares of Series C Cumulative Preferred Stock were entitled immediately prior

to such event under the preceding sentence shall be adjusted by multiplying such amount by a fraction, the numerator of which is the

number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common

Stock that were outstanding immediately prior to such event.

(B)           If

there are not sufficient assets available to permit payment in full of the Series C Liquidation Preference and the liquidation preferences

of all other classes and series of stock of the Corporation, if any, that rank on a parity with the Series C Cumulative Preferred Stock

in respect thereof, then the assets available for such distribution shall be distributed ratably to the holders of the Series C Cumulative

Preferred Stock and the holders of such parity shares in proportion to their respective liquidation preferences.

the merger or consolidation of the Corporation into or with another entity nor the merger or consolidation of any other entity into or

with the Corporation shall be deemed to be a liquidation, dissolution or winding-up of the Corporation within the meaning of this Section

-A-4-

Section 6.     Consolidation,

Merger, Etc. If the Corporation shall enter into any consolidation, merger, combination or other transaction in which the shares

of Common Stock are exchanged for or changed into other stock or securities, cash and/or any other property, then in any such case each

share of Series C Cumulative Preferred Stock shall at the same time be similarly exchanged or changed into an amount per share, subject

to the provision for adjustment hereinafter set forth, equal to 1,000 times the aggregate amount of stock, securities, cash and/or

any other property (payable in kind), as the case may be, into which or for which each share of Common Stock is changed or exchanged.

In the event that the Corporation shall at any time declare or pay any dividend on the Common Stock payable in shares of Common Stock,

or effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than

by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case

the amount set forth in the preceding sentence with respect to the exchange or change of shares of Series C Cumulative Preferred Stock

shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of shares of Common Stock outstanding

immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior

to such event.

Section 7.      Amendment.

While any Series C Cumulative Preferred Stock is issued and outstanding, the Articles of Incorporation shall not be amended in any manner,

including in a merger or consolidation, which would alter, change or repeal the powers, preferences or special rights of the Series C

Cumulative Preferred Stock so as to affect them adversely without the affirmative vote of the holders of at least two-thirds of the outstanding

shares of Series C Cumulative Preferred Stock, voting together as a single class.

Section 8.      Rank.

The Series C Cumulative Preferred Stock shall rank, with respect to the payment of dividends and upon liquidation, dissolution and winding-up,

junior to all other series of Cumulative Preferred Stock, unless the terms of any such series shall provide otherwise, and shall rank

senior to the Common Stock as to such matters.

Date of Adoption. The

Amendment was adopted by the Board of Directors of the Corporation on August 9, 2026.

Basis for Approval by Directors

Alone. The Amendment was duly adopted by the Board of Directors without shareholder approval. Shareholder approval was not required

pursuant to Section 13.1-639 of the Virginia Stock Corporation Act and Part A.1 of Article III of the Articles of Incorporation.

[Signature Page Follows]

-A-5-

IN WITNESS WHEREOF, these Articles

of Amendment are executed on behalf of the Corporation by its duly authorized officer this 10th day of August, 2026.

ACCENDRA

HEALTH, INC.

By:

Name:

Jonathan

A. Leon

Title:

Executive

Vice President and Chief Executive Officer

-A-6-

EXHIBIT B

Form of Right Certificate

Certificate No. R-_______

_____ Rights

NOT EXERCISABLE AFTER THE

FINAL EXPIRATION DATE (AS SUCH TERM IS DEFINED IN THE RIGHTS AGREEMENT) OR EARLIER IF REDEMPTION, EXCHANGE OR TERMINATION OCCURS. THE

RIGHTS ARE SUBJECT TO REDEMPTION AT $0.001 PER RIGHT AND TO EXCHANGE ON THE TERMS SET FORTH IN THE RIGHTS AGREEMENT. UNDER CERTAIN CIRCUMSTANCES,

RIGHTS THAT ARE OR WERE ACQUIRED OR BENEFICIALLY OWNED BY AN ACQUIRING PERSON OR ANY ASSOCIATES OR AFFILIATES THEREOF (AS SUCH TERMS

ARE DEFINED IN THE RIGHTS AGREEMENT), OR ANY SUBSEQUENT HOLDER OF SUCH RIGHTS, MAY BECOME

NULL AND VOID.

Right Certificate

ACCENDRA

HEALTH, Inc.

This certifies that ___________________________,

or his, her or its registered assigns, is the registered owner of the number of Rights set forth above, each of which entitles the owner

thereof, subject to the terms, provisions and conditions of the Section 382 Rights Agreement (as may be amended from time to time, the

“Rights Agreement”), dated as of August 10, 2026 between Accendra Health, Inc., a Virginia corporation (the

“Company”), and Computershare Trust Company, N.A., a federally chartered trust company, as rights agent (or any successor

rights agent) (the “Rights Agent”), to purchase from the Company at any time after the Distribution Date (as such

term is defined in the Rights Agreement) and prior to the Final Expiration Date (as such term is defined in the Rights Agreement) or

earlier under certain circumstances set forth in the Rights Agreement, at the office or offices of the Rights Agent designated for such

purpose, or at the office of its successor as Rights Agent, one one-thousandth of a fully paid non-assessable share of Series C Cumulative

Preferred Stock, par value $100.00 per share, of the Company (the “Preferred Shares”), at a purchase price of $15.00

per one one-thousandth of a Preferred Share (the “Purchase Price”), upon presentation and surrender of this Right

Certificate with the Form of Election to Purchase properly completed and duly executed, accompanied by such documentation as the Rights

Agent may reasonably request. The number of Rights evidenced by this Right Certificate (and the number of one one-thousandths of a Preferred

Share which may be purchased upon exercise hereof) set forth above, and the Purchase Price set forth above, are the number and Purchase

Price as of August 20, 2026 based on the Preferred Shares as constituted at such date. As provided in the Rights Agreement, the Purchase

Price and the number of one one-thousandths of a Preferred Share which may be purchased upon the exercise of the Rights evidenced by

this Right Certificate are subject to modification and adjustment upon the happening of certain events.

From and after the occurrence

of a Stock Acquisition Date (as defined in the Rights Agreement), if the Rights evidenced by this Right Certificate are or were acquired

or Beneficially Owned by an Acquiring Person or an Associate or Affiliate of an Acquiring Person, such Rights shall become void, and

any holder of such Rights shall thereafter have no right to exercise such Rights.

This Right Certificate is subject

to all of the terms, provisions and conditions of the Rights Agreement, which terms, provisions and conditions are incorporated herein

by this reference and made a part hereof, and to which Rights Agreement reference is made for a full description of the rights, limitations

of rights, obligations, duties and immunities hereunder of the Rights Agent, the Company and the holders of the Right Certificates. Copies

of the Rights Agreement are on file at the principal executive offices of the Company and the office or offices of the Rights Agent designated

for such purpose.

This Right Certificate, with

or without other Right Certificates, upon surrender at the office or offices of the Rights Agent designated for such purpose, accompanied

by such documentation as the Rights Agent may reasonably request, may be exchanged for another Right Certificate or Right Certificates

of like tenor and date evidencing Rights entitling the holder to purchase a like aggregate number of Preferred Shares as the Rights evidenced

by the Right Certificate or Right Certificates surrendered shall have entitled such holder to purchase. If this Right Certificate shall

be exercised in part, the holder shall be entitled to receive upon surrender hereof another Right Certificate or Right Certificates for

the number of whole Rights not exercised.

Subject to the provisions of

the Rights Agreement, at the Company’s option, the Rights evidenced by this Certificate (i) may be redeemed by the Company

at a redemption price of $0.001 per Right or (ii) may be exchanged in whole or in part for shares of common stock, par value $2.00

per share, of the Company, Preferred Shares, cash, debt securities, or other assets, property or instruments. The shares and other securities

transferred as part of the exchange may be transferred to a trust created upon such terms as the Board of Directors of the Company may

determine.

No fractional Preferred Shares

will be issued upon the exercise of any Right or Rights evidenced hereby (other than fractions which are integral multiples of one one-thousandth

of a Preferred Share, which may, at the election of the Company, be evidenced by depositary receipts), but in lieu thereof a cash payment

will be made, as provided in the Rights Agreement.

-B-2-

No holder of this Right Certificate,

as such, shall be entitled to vote or receive dividends or be deemed for any purpose the holder of the Preferred Shares or of any other

securities of the Company which may at any time be issuable on the exercise or exchange hereof, nor shall anything contained in the Rights

Agreement or herein be construed to confer upon the holder hereof, as such, any of the rights of a shareholder of the Company or any

right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or to give or withhold

consent to any corporate action, or to receive notice of meetings or other actions affecting shareholders (except as provided in the

Rights Agreement), or to receive dividends or subscription rights, or otherwise, until the Right or Rights evidenced by this Right Certificate

shall have been exercised or exchanged as provided in the Rights Agreement.

This Right Certificate shall

not be valid or obligatory for any purpose until it shall have been countersigned by the Rights Agent.

-B-3-

WITNESS the facsimile signature

of the proper officers of the Company and its corporate seal. Dated as of ____________.

accendra

health, Inc.

By:

Countersigned:

Rights

Agent

By:

Authorized

Signature

-B-4-

Form of Reverse Side of Right Certificate

FORM OF ASSIGNMENT

(To be executed by the registered holder if

such holder desires to transfer the Right Certificate.)

FOR VALUE RECEIVED, ___________________________________

hereby sells, assigns and transfers unto ______________________________________________________________________ (Please print name and

address of transferee)

this Right

Certificate, together with all right, title and interest therein, and does hereby irrevocably constitute and appoint _______________________________,

Attorney, to transfer the within Right Certificate on the books of the within-named Company, with full power of substitution.

Date:

Signature

Signature Guaranteed:

Signatures must be guaranteed

by an eligible guarantor institution (bank, stock broker or savings and loan association with membership in an approved signature medallion

program).

The undersigned hereby certifies

that the Rights evidenced by this Right Certificate are not Beneficially Owned by, were not acquired by the undersigned from, and are

not being assigned to an Acquiring Person or an Affiliate or Associate thereof).

Signature

-B-5-

Form of Reverse Side of Right Certificate -- continued

FORM OF ELECTION TO PURCHASE

(To be executed if holder desires

to exercise the Right Certificate.)

TO ACCENDRA HEALTH,

Inc.:

The undersigned hereby irrevocably

elects to exercise _______________ Rights represented by this Right Certificate to purchase the Preferred Shares issuable upon the exercise

of such Rights and requests that certificates for such Preferred Shares be issued in the name of:

Please insert Social Security or other identifying number:______________________________________________________________________________.

(Please print name and address)

If such number of Rights shall not

be all the Rights evidenced by this Right Certificate, a new Right Certificate for the balance remaining of such Rights shall be registered

in the name of and delivered to:

Please insert Social Security or other identifying number:______________________________________________________________________________.

(Please print name and address)

Dated:

________________________________ ___, _________________

Signature

(Signature must conform to the holder

specified on the Right Certificate)

Signature Guaranteed:

Signatures must be guaranteed

by an eligible guarantor institution (bank, stock broker or savings and loan association with membership in an approved signature medallion

program).

-B-6-

Form of Reverse Side of Right

Certificate -- continued

The undersigned hereby certifies

that the Rights evidenced by this Right Certificate are not Beneficially Owned by, were not acquired by the undersigned from, and are

not being assigned to an Acquiring Person or an Affiliate or Associate thereof.

Signature

NOTICE

The signature in the foregoing

Forms of Assignment and Election to Purchase must conform to the name as written upon the face of this Right Certificate in every particular,

without alteration or enlargement or any change whatsoever.

In the event that the certification

set forth above in the Form of Assignment or the Form of Election to Purchase, as the case may be, is not completed, such assignment

or election to purchase will not be honored

-B-7-

Exhibit C

UNDER CERTAIN CIRCUMSTANCES,

RIGHTS THAT ARE OR WERE ACQUIRED OR BENEFICIALLY OWNED BY AN ACQUIRING PERSON OR ANY ASSOCIATES OR AFFILIATES THEREOF (AS SUCH TERMS

ARE DEFINED IN THE RIGHTS AGREEMENT), OR ANY SUBSEQUENT HOLDER OF SUCH RIGHTS, MAY BECOME NULL AND VOID

SUMMARY OF RIGHTS TO PURCHASE

PREFERRED SHARES

On August 9, 2026 the Board

of Directors of Owens & Minor, Inc. (the “Company”) declared a dividend of one preferred share purchase right

(a “Right”) for each outstanding share of common stock, par value $2.00 per share, of the Company (the “Common

Shares”), outstanding on August 20, 2026 (the “Record Date”) to the shareholders of record on that date.

Each Right entitles the registered holder to purchase from the Company one one-thousandth of a share of Series C Cumulative Preferred

Stock, par value $100.00 per share, of the Company (the “Preferred Shares”), at a price of $15.00 per one one-thousandth

of a Preferred Share represented by a Right (the “Purchase Price”), subject to adjustment. The description and terms

of the Rights are set forth in a Rights Agreement (the “Rights Agreement”), dated as of August 10, 2026 between

the Company and Computershare Trust Company, N.A., a federally chartered trust company, as rights agent (or any successor rights agent),

as it may from time to time be amended or supplemented pursuant to its terms. Capitalized terms used but not defined in this summary

have the meanings ascribed to such terms in the Rights Agreement.

Until the earlier to occur

of (i) the Close of Business on the 10th day following the acquisition of Beneficial Ownership of 4.9% or more of the outstanding Common

Shares by a Person or group of affiliated or associated Persons (an “Acquiring Person”) (or, in the event that an

exchange is effected in accordance with Section 24 of the Rights Agreement and the Board of Directors determines that a later date is

advisable, then such later date) and (ii) 10 Business Days (or such later date as may be determined by action of the Board

of Directors prior to such time as any Person becomes an Acquiring Person) following the commencement of a tender offer or exchange offer

the consummation of which would result in the Beneficial Ownership by a Person or group of 4.9% or more of the outstanding Common Shares

(the earlier of such dates, the “Distribution Date”), the Rights will be evidenced by Common Share certificates with

a copy of this Summary of Rights attached thereto (unless such Rights are recorded in book-entry); provided, that each certificate

(or other evidence of book-entry or other uncertificated ownership) representing Common Shares outstanding as of the Close of Business

on the Record Date evidencing the Rights shall be deemed to incorporate by reference the terms of the Rights Agreement.

Acquiring Person means any

Person (other than an Exempt Person) who or which, together with all Affiliates and Associates of such Person, shall be the Beneficial

Owner of 4.9% or more of the Common Shares then outstanding, but shall not include (i) the Company, (ii) any Subsidiary of

the Company, (iii) any employee benefit plan of the Company or of any Subsidiary of the Company, (iv) any entity holding Common

Shares for or pursuant to the terms of any such employee benefit plan or (v) any Person who or which, together with all Affiliates

and Associates of such Person, at the time of the first public announcement of the Rights Agreement, is a Beneficial Owner of 4.9% or

more of the Common Shares then outstanding (a “Grandfathered Shareholder”); provided that if a Grandfathered

Shareholder becomes, after such time, the Beneficial Owner (other than pursuant to the vesting or exercise of any equity awards issued

to a member of the Board of Directors or pursuant to additional grants of any such equity awards to a member of the Board of Directors)

of any additional Common Shares (regardless of whether, thereafter or as a result thereof, there is an increase, decrease or no change

in the percentage of Common Shares then outstanding Beneficially Owned by such Grandfathered Shareholder) then such Grandfathered Shareholder

shall be deemed to be an Acquiring Person unless, upon such acquisition of Beneficial Ownership of additional Common Shares, such Person

is not the Beneficial Owner of 4.9% or more of the Common Shares then outstanding; provided, further, that upon the first

decrease of a Grandfathered Shareholder’s Beneficial Ownership below 4.9%, such Grandfathered Shareholder shall no longer be deemed

to be a Grandfathered Shareholder and this clause (v) shall have no further force or effect with respect to such Person. For the avoidance

of doubt, in the event that after the time of the first public announcement of the Rights Agreement, any agreement, arrangement or understanding

pursuant to which any Grandfathered Shareholder is deemed to be the Beneficial Owner of Common Shares is, directly or indirectly, replaced,

extended, amended or substituted with respect to the same or different Common Shares for any reason (including, without limitation, because

it expired, was settled in whole or in part, terminated or no longer confers any benefit to or imposes any obligation on the Grandfathered

Shareholder (or, as applicable, an Affiliate or Associate of the Grandfathered Shareholder)), then such agreement, arrangement or understanding

shall be considered the acquisition of Beneficial Ownership of additional Common Shares by the Grandfathered Shareholder and render such

Grandfathered Shareholder an Acquiring Person for purposes of the Rights Agreement unless, upon such acquisition of Beneficial Ownership

of additional Common Shares, such Person is not the Beneficial Owner of 4.9% or more of the Common Shares then outstanding.

“Beneficial Ownership”

shall include any securities (i) that such Person actually owns (directly or indirectly) or would be deemed to directly, indirectly or

constructively own (as determined for purposes of Section 382 of the Code or the Treasury Regulations), including any coordinated acquisition

of securities by any Persons who have a formal or informal understanding with respect to such acquisition (to the extent that ownership

of such securities would be attributed to such Persons under Section 382 of the Code and the Treasury Regulations), (ii) that such Person

beneficially owns, directly or indirectly, as determined pursuant to Rule 13d-3 of the Exchange Act as in effect on the date of the Rights

Agreement, including pursuant to any contract, arrangement, understanding, relationship, or otherwise as set forth in Rule 13d-3, but

only if the effect of such arrangement, understanding, relationship, or otherwise is to treat such Persons as an “entity”

under Section 1.382-3(a)(1) of the Treasury Regulations, or (iii) that are Beneficially Owned (within the meaning of the preceding subsections

of this this definition), directly or indirectly, by any other Person with which such Person has any agreement, arrangement or understanding

(whether or not in writing and other than customary agreements with and between underwriters and selling group members with respect to

a bona fide public offering of securities), but only if the effect of such agreement, arrangement or understanding is to treat such Persons

as an “entity” under Section 1.382-3(a)(1) of the Treasury Regulations; provided, however, that a Person shall not be deemed

the “Beneficial Owner” of, or to “Beneficially Own,” any security if such agreement, arrangement or understanding

(a) arises solely from a revocable proxy or consent given in response to a public proxy or consent solicitation made pursuant to, and

in accordance with, the applicable provisions of the Exchange Act and (b) is not also then reportable by such Person on Schedule 13D

under the Exchange Act (or any comparable or successor report). Notwithstanding anything in this definition to the contrary, the phrase

“then outstanding,” when used with reference to a Person’s Beneficial Ownership of securities of the Company, means

the number of such securities then issued and outstanding together with the number of such securities not then actually issued and outstanding

which such Person would be deemed to Beneficially Own hereunder.

-C-2-

The Rights Agreement provides

that, until the Distribution Date (or the earlier expiration or redemption of the Rights), the Rights will be transferred with and only

with the Common Shares. New Rights will accompany any new Common Shares issued by the Company after the Record Date, until the Distribution

Date (or the earlier expiration or redemption of the Rights). Until the Distribution Date (or earlier redemption or expiration of the

Rights), new Common Share certificates issued after the Record Date or upon transfer or new issuance of Common Shares will contain a

notation incorporating the Rights Agreement by reference. Until the Distribution Date (or earlier redemption or expiration of the Rights),

the surrender for transfer of any certificates for Common Shares outstanding as of the Record Date, even without such notation or a copy

of this Summary of Rights being attached thereto, will also constitute the transfer of the Rights associated with the Common Shares represented

by such certificate. As soon as practicable following the Distribution Date, separate certificates evidencing the Rights (“Right

Certificates”) will be mailed to holders of record of the Common Shares as of the Distribution Date, and such separate Right

Certificates alone will evidence the Rights (unless such Rights are recorded in book-entry).

The Rights are not exercisable

until the Distribution Date. The Rights will expire on the Close of Business on August 10, 2029 (the “Final Expiration

Date”).

The Purchase Price payable,

and the number of Preferred Shares or other securities or property issuable, upon exercise of the Rights is subject to adjustment from

time to time to prevent dilution (i) in the event of a stock dividend on, or a subdivision, combination or reclassification of,

the Preferred Shares; (ii) upon the grant to holders of the Preferred Shares of certain rights or warrants to subscribe for or purchase

Preferred Shares at a price, or securities convertible into Preferred Shares with a conversion price, less than the then current market

price of the Preferred Shares; or (iii) upon the distribution to holders of the Preferred Shares of evidences of indebtedness or

assets (excluding regular periodic cash dividends paid out of earnings or retained earnings or dividends payable in Preferred Shares)

or of subscription rights or warrants (other than those referred to above).

The number of outstanding

Rights and the number of Preferred Shares issuable upon exercise of each Right are also subject to adjustment in the event of a stock

split of the Common Shares or a stock dividend on the Common Shares payable in Common Shares or subdivisions, consolidations or combinations

of the Common Shares occurring, in any such case, prior to the Distribution Date.

-C-3-

Preferred Shares purchasable

upon exercise of the Rights will not be redeemable. Each Preferred Share will be entitled to a quarterly dividend payment of 1,000 multiplied

by the dividend declared per Common Share. In the event of liquidation, the holders of the Preferred Shares will be entitled to a payment

per share equal to 1,000 multiplied by the aggregate payment made per Common Share. Each Preferred Share will have 1,000 votes,

voting together with the Common Shares. In the event of any merger, consolidation or other transaction in which Common Shares are exchanged,

each Preferred Share will be entitled to receive 1,000 multiplied by the amount received per Common Share.

From and after the time any

Person becomes an Acquiring Person, if the Rights evidenced by this Right Certificate are or were acquired or Beneficially Owned by an

Acquiring Person or an Associate or Affiliate of an Acquiring Person (as such terms are defined in the Rights Agreement), such Rights

shall become void, and any holder of such Rights shall thereafter have no right to exercise such Rights.

If any Person becomes an

Acquiring Person, proper provision shall be made so that each holder of a Right, other than Rights Beneficially Owned by the Acquiring

Person and its Affiliates and Associates (all of which will thereafter be void), will thereafter have the right to receive upon exercise

that number of Common Shares having a market value of two times the exercise price of the Right. If the Board of Directors so elects,

the Company may deliver upon payment of the exercise price of a Right an amount of cash, securities, or other property equivalent in

value to the Common Shares issuable upon exercise of a Right.

If, at any time after a Person

becomes an Acquiring Person, the Company is acquired in a merger or other business combination transaction or 50% or more of its consolidated

assets or Earning Power (as defined in the Rights Agreement) are sold, proper provision will be made so that each holder of a Right will

thereafter have the right to receive, upon the exercise thereof at the then current exercise price of the Right, that number of shares

of common stock of the acquiring company which at the time of such transaction will have a market value of two times the exercise price

of the Right.

At any time after any Person

becomes an Acquiring Person and prior to the acquisition by any Person or group of a majority of the outstanding Common Shares, the Board

of Directors may exchange the Rights (other than Rights owned by such Person or group which have become void), in whole or in part, at

an exchange ratio of one Common Share per Right (subject to adjustment). The shares and other securities transferred as part of the exchange

may be transferred to a trust created upon such terms as the Board of Directors of the Company may determine.

With certain exceptions,

no adjustment in the Purchase Price will be required until cumulative adjustments require an adjustment of at least 1% in such Purchase

Price. No fractional Preferred Shares will be issued (other than fractions which are integral multiples of one one-thousandth of a Preferred

Share, which may, at the election of the Company, be evidenced by depositary receipts), and in lieu thereof, an adjustment in cash will

be made based on the market price of the Preferred Shares on the last trading day prior to the date of exercise.

At any time prior to the

time any Person becomes an Acquiring Person, the Board of Directors may redeem the Rights in whole, but not in part, at a price of $0.001

per Right (the “Redemption Price”). The redemption of the Rights may be made effective at such time, on such basis

and with such conditions as the Board of Directors in its sole discretion may establish. Immediately upon any redemption of the Rights,

the right to exercise the Rights will terminate and the only right of the holders of Rights will be to receive the Redemption Price.

-C-4-

The terms of the Rights may

be amended by the Board of Directors without the consent of the holders of the Rights. However, from and after such time as any Person

becomes an Acquiring Person, the Rights Agreement shall not be amended or supplemented in any manner which would adversely affect the

interests of the holders of Rights (other than an Acquiring Person and its Affiliates and Associates).

Until a Right is exercised,

the holder thereof, as such, will have no rights as a shareholder of the Company, including, without limitation, the right to vote or

to receive dividends.

A copy of the Rights Agreement

has been filed with the Securities and Exchange Commission as an Exhibit to a Current Report on Form 8-K. A copy of the Rights Agreement

is available free of charge from the Company. The foregoing summary of the Rights does not purport to be complete and is qualified in

its entirety by reference to the Rights Agreement, which is hereby incorporated herein by reference.

-C-5-

EX-99.1 — EXHIBIT 99.1

EX-99.1

Filename: tm2622667d3_ex99-1.htm · Sequence: 4

Exhibit 99.1

Accendra Health

Announces Adoption of Tax Asset Preservation Plan

To Protect Long

Term Shareholder Value

RICHMOND,

VA – August 10, 2026 – Accendra Health, Inc. (NYSE: ACH) (the Company) announced

today that its Board of Directors adopted a Section 382 Rights Agreement (the “Tax Asset Preservation Plan”) designed

to protect long-term shareholder value by facilitating the Company’s ability to preserve its net operating loss carryforwards (“NOLs”)

and certain other tax attributes.

A company generally

experiences an ownership change if the percentage of the value of its stock owned by certain “5-percent shareholders,” as

such term is defined in Section 382 of the Code, increases by more than 50 percentage points over a rolling three-year period. The

Tax Asset Preservation Plan is intended to reduce the likelihood of such an “ownership change” under Section 382 of

the Code by deterring any person or group from acquiring beneficial ownership of 4.9% or more of the Company’s outstanding common

stock.

The Tax Asset Preservation

Plan is similar to those adopted by numerous other public companies with significant NOLs. The Tax Asset Preservation Plan is not designed

to prevent any action that the Board of Directors determines to be in the best interest of the Company, and will help to ensure that

the Board of Directors remains in the best position to discharge its fiduciary duties.

If the Company

experiences an “ownership change,” as such term is defined in Section 382 of the Internal Revenue Code of 1986, as amended

(the “Code”) all holders of rights (other than any triggering person) will be entitled to acquire shares of common stock

at a 50% discount or the Company may exchange each right held by such holders for one share of common stock.

The Tax Asset Preservation Plan took effect

on August 10, 2026 and is scheduled to continue in effect until August 10, 2029, unless terminated earlier in accordance with its terms.

Additional information

about the Tax Asset Preservation Plan will be available on a Form 8-K to be filed by the Company with the U.S. Securities and Exchange

Commission.

August 10 Investor Conference

Call for Second Quarter 2026 Financial Results

As previously announced,

Accendra Health will host a conference call for investors and analysts on August 10, 2026, at 8:00 a.m. E.T. Participants may

access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access

code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations

page of the Accendra Health website available at investors.accendrahealth.com/events-and-presentations/. A replay of the webcast

can be accessed following the presentation at the link provided above.

Safe Harbor

This

release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public

in compliance with the SEC’s Fair Disclosure Regulation. This release contains certain “forward looking” statements

made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are

not limited to, the statements in this release regarding our future prospects and performance, including our expectations with respect

to our financial performance, our 2026 financial results, our expectations regarding the performance of our business following the completion

of the sale of the Products & Healthcare Services business, uncertainty about the time required to select and appoint the Company’s

next President and CEO, our cost saving initiatives, future indebtedness and growth, industry trends, as well as statements related to

our expectations regarding the performance of our business, including our ability to address macro and market conditions. Forward-looking

statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially

from those projected or contemplated in the forward-looking statements. Investors should refer to the Company’s Annual Report on

Form 10-K for the year ended December 31, 2025, filed with the SEC on February 20, 2026, including the section captioned

“Item 1A. Risk Factors,” as applicable, and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K

filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause the Company’s actual results

to differ materially from its current estimates. These filings are available at www.accendrahealth.com.

Given these risks and uncertainties, the Company can give no assurance that any forward-looking statements will, in fact, transpire and,

therefore, cautions investors not to place undue reliance on them. The Company specifically disclaims any obligation to update or revise

any forward-looking statements, whether as a result of new information, future developments or otherwise.

About Accendra Health

Accendra

Health, Inc. (NYSE: ACH) is a leading nationwide provider of products, technology, and services that support health beyond the hospital

for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better

health outcomes and improve quality of life for people living with chronic, complex health conditions. Backed by the industry-leading

expertise of our Apria and Byram brands, Accendra Health is reimagining the future of home-based care. To learn more about our broad

portfolio of essentials for diabetes, sleep health, wound care, respiratory care, urology, and ostomy, visit www.accendrahealth.com.

CONTACT:

Investors

Will Parrish

Vice President, Strategy, Corporate

Development, & Investor Relations

Investor.Relations@accendra.com

Media

Darla Turner

media@accendra.com

ACH-CORP

ACH-IR

SOURCE:

Accendra Health, Inc.

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 9

v3.26.1

Cover

Aug. 09, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Aug. 09, 2026

Current Fiscal Year End Date

--12-31

Entity File Number

001-09810

Entity Registrant Name

Accendra

Health, Inc.

Entity Central Index Key

0000075252

Entity Tax Identification Number

54-1701843

Entity Incorporation, State or Country Code

Entity Address, Address Line One

4435 Waterfront Drive, Suite 300

Entity Address, City or Town

Glen Allen

Entity Address, State or Province

Entity Address, Postal Zip Code

23060

City Area Code

804

Local Phone Number

277-4304

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, $2.00 par value per share

Trading Symbol

ACH

Security Exchange Name

NYSE

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name:

dei_CurrentFiscalYearEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:gMonthDayItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration